: The AMEDEO Literature Guide

Home The Word Brain

My Amedeo

FAQ

Privacy

About

Flying Publisher

COVID-19: Daily Top 10 Papers

Autoimmune Disorders

Free Subscription

Articles published in J Neurol
Retrieve available abstracts of 406 articles:
HTML format

Single Articles

August 2021

FIONDA L, Di Pasquale A, Morino S, Leonardi L, et al
Changes of clinical, neurophysiological and nerve ultrasound characteristics in CIDP over time: a 3-year follow-up.
J Neurol. 2021;268:3011-3019.
PubMed Abstract available

CORTESE R, Prosperini L, Stasolla A, Haggiag S, et al
Clinical course of central nervous system demyelinating neurological adverse events associated with anti-TNF therapy.
J Neurol. 2021;268:2895-2899.
PubMed Abstract available

CILINGIR V, Batur M
First measured retinal nerve fiber layer thickness in RRMS can be used as a biomarker for the course of the disease: threshold value discussions.
J Neurol. 2021;268:2858-2865.
PubMed Abstract available

WANSCHITZ JV, Kaml M, Pfausler B, Helbok R, et al
Myasthenic crisis following SARS-CoV-2 infection and delayed virus clearance in a patient treated with rituximab: clinical course and 6-month follow-up.
J Neurol. 2021;268:2700-2702.
PubMed

July 2021

FERRARO D, Iaffaldano P, Guerra T, Inglese M, et al
Risk of multiple sclerosis relapses when switching from fingolimod to cell-depleting agents: the role of washout duration.
J Neurol. 2021 Jul 22. pii: 10.1007/s00415-021-10708.
PubMed Abstract available

RAUMA I, Mustonen T, Seppa JM, Ukkonen M, et al
Safety of alemtuzumab in a nationwide cohort of Finnish multiple sclerosis patients.
J Neurol. 2021 Jul 13. pii: 10.1007/s00415-021-10664.
PubMed Abstract available

NIESSEN A, Schwarz B, Urban M, Kramer S, et al
Aseptic meningitis after glatiramer acetate.
J Neurol. 2021;268:2589-2590.
PubMed

STARMANS NLP, van Dijk MR, Kappelle LJ, Frijns CJM, et al
Sneddon syndrome: a comprehensive clinical review of 53 patients.
J Neurol. 2021;268:2450-2457.
PubMed Abstract available

MASUCCIO FG, Barra M, Claudio G, Claudio S, et al
A rare case of acute motor axonal neuropathy and myelitis related to SARS-CoV-2 infection.
J Neurol. 2021;268:2327-2330.
PubMed Abstract available

June 2021

CHISARI CG, Comi G, Filippi M, Paolicelli D, et al
PML risk is the main factor driving the choice of discontinuing natalizumab in a large multiple sclerosis population: results from an Italian multicenter retrospective study.
J Neurol. 2021 Jun 28. pii: 10.1007/s00415-021-10676.
PubMed Abstract available

SANKARI SE, Van Essche C, van Pesch V
Cutaneous diseases related to a hyperactive T-cell response in ocrelizumab-treated multiple sclerosis patients.
J Neurol. 2021 Jun 28. pii: 10.1007/s00415-021-10679.
PubMed

KOGEL AK, Gold R, Schneider R
CMV meningitis associated with dimethyl fumarate therapy-induced lymphopenia in a multiple sclerosis patient.
J Neurol. 2021 Jun 27. pii: 10.1007/s00415-021-10661.
PubMed

S G, S L, C Z, A N, et al
Serological response to SARS-CoV-2 vaccination in multiple sclerosis patients treated with fingolimod or ocrelizumab: an initial real-life experience.
J Neurol. 2021 Jun 26. pii: 10.1007/s00415-021-10663.
PubMed Abstract available

HANNINEN K, Viitala M, Atula S, Laakso SM, et al
Initial treatment strategy and clinical outcomes in Finnish MS patients: a propensity-matched study.
J Neurol. 2021 Jun 25. pii: 10.1007/s00415-021-10673.
PubMed Abstract available

HAVLA J, Schultz Y, Zimmermann H, Hohlfeld R, et al
First manifestation of multiple sclerosis after immunization with the Pfizer-BioNTech COVID-19 vaccine.
J Neurol. 2021 Jun 11. pii: 10.1007/s00415-021-10648.
PubMed

KIM SH, Baek SH, Lee SU, Yu S, et al
Optic disc edema as a sole manifestation of anti-GQ1b antibody syndrome.
J Neurol. 2021;268:2263-2266.
PubMed

DAO LM, Machule ML, Bacher P, Hoffmann J, et al
Decreased inflammatory cytokine production of antigen-specific CD4(+) T cells in NMDA receptor encephalitis.
J Neurol. 2021;268:2123-2131.
PubMed Abstract available

LLORENTE AYUSO L, Torres Rubio P, Beijinho do Rosario RF, Giganto Arroyo ML, et al
Bickerstaff encephalitis after COVID-19.
J Neurol. 2021;268:2035-2037.
PubMed

May 2021

JURYNCZYK M, Klimiec-Moskal E, Kong Y, Hurley S, et al
Elucidating distinct clinico-radiologic signatures in the borderland between neuromyelitis optica and multiple sclerosis.
J Neurol. 2021 May 27. pii: 10.1007/s00415-021-10619.
PubMed Abstract available

CHEN MH, Chiaravalloti ND, DeLuca J
Neurological update: cognitive rehabilitation in multiple sclerosis.
J Neurol. 2021 May 24. pii: 10.1007/s00415-021-10618.
PubMed Abstract available

HOU Y, Shao K, Yan Y, Dai T, et al
Anti-HMGCR myopathy overlaps with dermatomyositis-like rash: a distinct subtype of idiopathic inflammatory myopathy.
J Neurol. 2021 May 21. pii: 10.1007/s00415-021-10621.
PubMed Abstract available

KILIC MA, Yoruk Yildirim ZN, Oner A, Yesil E, et al
Pediatric LGI1 and CASPR2 autoimmunity associated with COVID 19: Morvan syndrome.
J Neurol. 2021 May 18. pii: 10.1007/s00415-021-10614.
PubMed

ZRZAVY T, Pfitzner A, Flachenecker P, Rommer P, et al
Effects of normobaric hypoxic endurance training on fatigue in patients with multiple sclerosis: a randomized prospective pilot study.
J Neurol. 2021 May 18. pii: 10.1007/s00415-021-10596.
PubMed Abstract available

HILDESHEIM FE, Benedict RHB, Zivadinov R, Dwyer MG, et al
Nucleus basalis of Meynert damage and cognition in patients with multiple sclerosis.
J Neurol. 2021 May 16. pii: 10.1007/s00415-021-10594.
PubMed Abstract available

TOMMASIN S, Cocozza S, Taloni A, Gianni C, et al
Machine learning classifier to identify clinical and radiological features relevant to disability progression in multiple sclerosis.
J Neurol. 2021 May 10. pii: 10.1007/s00415-021-10605.
PubMed Abstract available

RUGGIERI S, Petracca M, De Giglio L, De Luca F, et al
A matter of atrophy: differential impact of brain and spine damage on disability worsening in multiple sclerosis.
J Neurol. 2021 May 3. pii: 10.1007/s00415-021-10576.
PubMed Abstract available

THOUIN A, Gastaldi M, Woodhall M, Jacobson L, et al
Comparison of N-methyl-D-aspartate receptor antibody assays using live or fixed substrates.
J Neurol. 2021;268:1818-1826.
PubMed Abstract available

April 2021

GUGER M, Enzinger C, Leutmezer F, Di Pauli F, et al
Long-term outcome and predictors of long-term disease activity in natalizumab-treated patients with multiple sclerosis: real life data from the Austrian MS Treatment Registry.
J Neurol. 2021 Apr 22. pii: 10.1007/s00415-021-10559.
PubMed Abstract available

COVEY TJ, Golan D, Doniger GM, Sergott R, et al
Visual evoked potential latency predicts cognitive function in people with multiple sclerosis.
J Neurol. 2021 Apr 18. pii: 10.1007/s00415-021-10561.
PubMed Abstract available

CENTONZE D, Rocca MA, Gasperini C, Kappos L, et al
Disease-modifying therapies and SARS-CoV-2 vaccination in multiple sclerosis: an expert consensus.
J Neurol. 2021 Apr 12. pii: 10.1007/s00415-021-10545.
PubMed Abstract available

WILF-YARKONI A, Lotan I, Steiner I, Hellmann MA, et al
Chronic low-dose intravenous immunoglobulins as steroid-sparing therapy in myasthenia gravis.
J Neurol. 2021 Apr 7. pii: 10.1007/s00415-021-10544.
PubMed Abstract available

NYGAARD MKE, Langeskov-Christensen M, Dalgas U, Eskildsen SF, et al
Cortical diffusion kurtosis imaging and thalamic volume are associated with cognitive and walking performance in relapsing-remitting multiple sclerosis.
J Neurol. 2021 Apr 7. pii: 10.1007/s00415-021-10543.
PubMed Abstract available

ZEIDAN S, Maillart E, Louapre C, Roux T, et al
COVID-19 infection in NMO/SD patients: a French survey.
J Neurol. 2021;268:1188-1190.
PubMed

URBAIN F, Puyade M, Labeyrie C, Maubeuge N, et al
Hematopoietic stem cell transplantation in chronic inflammatory demyelinating polyneuropathy: French experience about four patients, under the behalf of French society for bone marrow transplantation.
J Neurol. 2021;268:1536-1539.
PubMed

KAPOOR M, Keh R, Compton L, Morrow S, et al
Subcutaneous immunoglobulin dose titration to clinical response in inflammatory neuropathy.
J Neurol. 2021;268:1485-1490.
PubMed Abstract available

NETRAVATHI M, Holla VV, Nalini A, Yadav R, et al
Myelin oligodendrocyte glycoprotein-antibody-associated disorder: a new inflammatory CNS demyelinating disorder.
J Neurol. 2021;268:1419-1433.
PubMed Abstract available

CHAUDHARY UJ, Rajabally YA
Underdiagnosis and diagnostic delay in chronic inflammatory demyelinating polyneuropathy.
J Neurol. 2021;268:1366-1373.
PubMed Abstract available

March 2021

MATHEY G, Pische G, Soudant M, Pittion-Vouyovitch S, et al
Long-term analysis of patients with benign multiple sclerosis: new insights about the disability course.
J Neurol. 2021 Mar 31. pii: 10.1007/s00415-021-10501.
PubMed Abstract available

PINTER D, Kober SE, Fruhwirth V, Berger L, et al
MRI correlates of cognitive improvement after home-based EEG neurofeedback training in patients with multiple sclerosis: a pilot study.
J Neurol. 2021 Mar 30. pii: 10.1007/s00415-021-10530.
PubMed Abstract available

OZAWA Y, Uzawa A, Yasuda M, Kojima Y, et al
Long-term outcomes and prognostic factors in generalized myasthenia gravis.
J Neurol. 2021 Mar 27. pii: 10.1007/s00415-021-10520.
PubMed Abstract available

SVACINA MKR, Kohle F, Sprenger A, Lehmann HC, et al
Could symptom overlap of COVID-19 and Guillain-Barre syndrome mask an epidemiological association?
J Neurol. 2021 Mar 17. pii: 10.1007/s00415-021-10515.
PubMed

HJAERESEN S, Sejbaek T, Axelsson M, Vinslov-Jensen H, et al
The levels of the serine protease HTRA1 in cerebrospinal fluid correlate with progression and disability in multiple sclerosis.
J Neurol. 2021 Mar 4. pii: 10.1007/s00415-021-10489.
PubMed Abstract available

RATH J, Zulehner G, Schober B, Grisold A, et al
Cerebrospinal fluid analysis in Guillain-Barre syndrome: value of albumin quotients.
J Neurol. 2021 Mar 2. pii: 10.1007/s00415-021-10479.
PubMed Abstract available

VAN ROSMALEN MHJ, Goedee HS, van der Gijp A, Witkamp TD, et al
Quantitative assessment of brachial plexus MRI for the diagnosis of chronic inflammatory neuropathies.
J Neurol. 2021;268:978-988.
PubMed Abstract available

MATHIS S, Soulages A, Le Masson G, Vallat JM, et al
Epidemics and outbreaks of peripheral nervous system disorders: I. infectious and immune-mediated causes.
J Neurol. 2021;268:879-890.
PubMed Abstract available

February 2021

GOUDOT M, Frismand S, Hopes L, Verger A, et al
Recurrent seizures of autoimmune origin: emerging phenotypes.
J Neurol. 2021 Feb 27. pii: 10.1007/s00415-021-10457.
PubMed Abstract available

TOLEDANO-ILLAN C, Esparragosa Vazquez I, Zelaya Huerta MV, Rosales Castillo JJ, et al
Autoimmune glial fibrillary acidic protein astrocytopathy: case report of a treatable cause of rapidly progressive dementia.
J Neurol. 2021 Feb 26. pii: 10.1007/s00415-021-10484.
PubMed

BUCELLO S, Annovazzi P, Ragonese P, Altieri M, et al
Real world experience with teriflunomide in multiple sclerosis: the TER-Italy study.
J Neurol. 2021 Feb 22. pii: 10.1007/s00415-021-10455.
PubMed Abstract available

WALZL D, Solomon AJ, Stone J
Functional neurological disorder and multiple sclerosis: a systematic review of misdiagnosis and clinical overlap.
J Neurol. 2021 Feb 21. pii: 10.1007/s00415-021-10436.
PubMed Abstract available

CAPONE F, Ferraro E, Motolese F, Di Lazzaro V, et al
COVID-19 in multiple sclerosis patients treated with dimethyl fumarate.
J Neurol. 2021 Feb 20. pii: 10.1007/s00415-021-10446.
PubMed

FILIPPI M, Capra R, Centonze D, Gasperini C, et al
Therapeutic recommendations and seasonal influenza vaccine for multiple sclerosis patients in treatment with ocrelizumab: an expert consensus.
J Neurol. 2021 Feb 20. pii: 10.1007/s00415-021-10466.
PubMed

JAKIMOVSKI D, Benedict RHB, Weinstock-Guttman B, Ozel O, et al
Visual deficits and cognitive assessment of multiple sclerosis: confounder, correlate, or both?
J Neurol. 2021 Feb 15. pii: 10.1007/s00415-021-10437.
PubMed Abstract available

YOO JS, Kim YS, Kim HY, Kwon HS, et al
Comparison of patients with transient and sustained increments of antiphospholipid antibodies after acute ischemic stroke.
J Neurol. 2021 Feb 6. pii: 10.1007/s00415-021-10432.
PubMed Abstract available

MUNIZ-CASTRILLO S, Vogrig A, Montagnac C, Joubert B, et al
Familial autoimmunity in neurological patients with GAD65 antibodies: an interview-based study.
J Neurol. 2021 Feb 5. pii: 10.1007/s00415-021-10424.
PubMed Abstract available

TREABA CA, Herranz E, Barletta VT, Mehndiratta A, et al
The relevance of multiple sclerosis cortical lesions on cortical thinning and their clinical impact as assessed by 7.0-T MRI.
J Neurol. 2021 Feb 1. pii: 10.1007/s00415-021-10400.
PubMed Abstract available

MARTIN T, Duke S, Kumar V, Fadhil A, et al
NMDAR antibody encephalitis overlapping with CLIPPERS syndrome in a psoriasis patient on adalimumab.
J Neurol. 2021;268:714-716.
PubMed

SCHROTER N, Weiller C, Rauer S, Waller CF, et al
Anti-glycin-receptor antibody related stiff-person syndrome under treatment with an immune checkpoint inhibitor.
J Neurol. 2021;268:709-711.
PubMed

OKADA K, Seki M, Yaguchi H, Sakuta K, et al
Polyradiculoneuropathy induced by immune checkpoint inhibitors: a case series and review of the literature.
J Neurol. 2021;268:680-688.
PubMed Abstract available

BERGMAN J, Burman J, Bergenheim T, Svenningsson A, et al
Intrathecal treatment trial of rituximab in progressive MS: results after a 2-year extension.
J Neurol. 2021;268:651-657.
PubMed Abstract available

January 2021

JORDAN B, Uer O, Buchholz T, Spens A, et al
Physical fatigability and muscle pain in patients with Hashimoto thyroiditis.
J Neurol. 2021 Jan 28. pii: 10.1007/s00415-020-10394.
PubMed Abstract available

LUCCHINI M, Prosperini L, Buscarinu MC, Centonze D, et al
Predictors of lymphocyte count recovery after dimethyl fumarate-induced lymphopenia in people with multiple sclerosis.
J Neurol. 2021 Jan 26. pii: 10.1007/s00415-021-10412.
PubMed Abstract available

HARES K, Kemp K, Loveless S, Rice CM, et al
KIF5A and the contribution of susceptibility genotypes as a predictive biomarker for multiple sclerosis.
J Neurol. 2021 Jan 23. pii: 10.1007/s00415-020-10373.
PubMed Abstract available

BOREMALM M, Sundstrom P, Salzer J
Discontinuation and dose reduction of rituximab in relapsing-remitting multiple sclerosis.
J Neurol. 2021 Jan 21. pii: 10.1007/s00415-021-10399.
PubMed Abstract available

FAN Q, Hu Y, Wang X, Zhao B, et al
Guillain-Barre syndrome in patients treated with immune checkpoint inhibitors.
J Neurol. 2021 Jan 21. pii: 10.1007/s00415-021-10404.
PubMed Abstract available

CHISARI CG, Sgarlata E, Arena S, Toscano S, et al
Rituximab for the treatment of multiple sclerosis: a review.
J Neurol. 2021 Jan 8. pii: 10.1007/s00415-020-10362.
PubMed Abstract available

KEVER A, Buyukturkoglu K, Riley CS, De Jager PL, et al
Social support is linked to mental health, quality of life, and motor function in multiple sclerosis.
J Neurol. 2021 Jan 3. pii: 10.1007/s00415-020-10330.
PubMed Abstract available

GELIBTER S, Pisa M, Croese T, Dalla Costa G, et al
Neutrophil-to-lymphocyte ratio: a marker of neuro-inflammation in multiple sclerosis?
J Neurol. 2021 Jan 3. pii: 10.1007/s00415-020-10322.
PubMed Abstract available

ZHUO Z, Li Y, Duan Y, Cao G, et al
Subtyping relapsing-remitting multiple sclerosis using structural MRI.
J Neurol. 2021 Jan 2. pii: 10.1007/s00415-020-10376.
PubMed Abstract available

MONTE G, Spagni G, Damato V, Iorio R, et al
Acetylcholine receptor antibody positivity rate in ocular myasthenia gravis: a matter of age?
J Neurol. 2021 Jan 2. pii: 10.1007/s00415-020-10342.
PubMed Abstract available

WOO MS, Steins D, Haussler V, Kohsar M, et al
Control of SARS-CoV-2 infection in rituximab-treated neuroimmunological patients.
J Neurol. 2021;268:5-7.
PubMed

STOECKLEIN VM, Kellert L, Patzig M, Kupper C, et al
Extended stereotactic brain biopsy in suspected primary central nervous system angiitis: good diagnostic accuracy and high safety.
J Neurol. 2021;268:367-376.
PubMed Abstract available

KASS-ILIYYA L, Snowden JA, Thorpe A, Jessop H, et al
Autologous haematopoietic stem cell transplantation for refractory stiff-person syndrome: the UK experience.
J Neurol. 2021;268:265-275.
PubMed Abstract available

December 2020

NEMA E, Kalina A, Nikolai T, Vyhnalek M, et al
Correction to: Spatial navigation in early multiple sclerosis: a neglected cognitive marker of the disease?
J Neurol. 2020 Dec 30. pii: 10.1007/s00415-020-10294.
PubMed

NEUSS F, von Podewils F, Wang ZI, Susse M, et al
Epileptic seizures in multiple sclerosis: prevalence, competing causes and diagnostic accuracy.
J Neurol. 2020 Dec 15. pii: 10.1007/s00415-020-10346.
PubMed Abstract available

MANTERO V, Rigamonti A, Basilico P, Crespi M, et al
Mild COVID-19 infection in an NMO patient treated with tocilizumab: a confirmation of anti-IL-6 protective role?
J Neurol. 2020;267:3465-3466.
PubMed

ZACHARIADIS A, Tulbu A, Strambo D, Dumoulin A, et al
Transverse myelitis related to COVID-19 infection.
J Neurol. 2020;267:3459-3461.
PubMed

November 2020

PREZIOSA P, Rocca MA, Nozzolillo A, Moiola L, et al
COVID-19 in cladribine-treated relapsing-remitting multiple sclerosis patients: a monocentric experience.
J Neurol. 2020 Nov 20. pii: 10.1007/s00415-020-10309.
PubMed

BRACAGLIA M, Naldi I, Govoni A, Brillanti Ventura D, et al
Acute inflammatory demyelinating polyneuritis in association with an asymptomatic infection by SARS-CoV-2.
J Neurol. 2020;267:3166-3168.
PubMed

October 2020

SIMONSEN CS, Flemmen HO, Broch L, Brunborg C, et al
The course of multiple sclerosis rewritten: a Norwegian population-based study on disease demographics and progression.
J Neurol. 2020 Oct 22. pii: 10.1007/s00415-020-10279.
PubMed Abstract available

ZECCA C, Disanto G, Sacco R, MacLachlan S, et al
Increasing cancer risk over calendar year in people with multiple sclerosis: a case-control study.
J Neurol. 2020 Oct 21. pii: 10.1007/s00415-020-10170.
PubMed Abstract available

ARNETH B
Contributions of T cells in multiple sclerosis: what do we currently know?
J Neurol. 2020 Oct 20. pii: 10.1007/s00415-020-10275.
PubMed Abstract available

LOTAN I, Hellmann MA, Wilf-Yarkoni A, Steiner I, et al
Exacerbation of myasthenia gravis following corticosteroid treatment: what is the evidence? A systematic review.
J Neurol. 2020 Oct 16. pii: 10.1007/s00415-020-10264.
PubMed Abstract available

DOIG D, McNamara C, Mewasingh L, Beri S, et al
Autoimmune cortical encephalitis in two children with anti-myelin oligodendrocyte glycoprotein (MOG) antibody.
J Neurol. 2020 Oct 14. pii: 10.1007/s00415-020-10260.
PubMed Abstract available

SRIWASTAVA S, Tandon M, Kataria S, Daimee M, et al
New onset of ocular myasthenia gravis in a patient with COVID-19: a novel case report and literature review.
J Neurol. 2020 Oct 12. pii: 10.1007/s00415-020-10263.
PubMed Abstract available

WILLIS MD, Robertson NP
Multiple sclerosis: early indicators of disease and assessing future risk.
J Neurol. 2020 Oct 8. pii: 10.1007/s00415-020-10239.
PubMed

PARSONS T, Banks S, Bae C, Gelber J, et al
COVID-19-associated acute disseminated encephalomyelitis (ADEM).
J Neurol. 2020;267:2799-2802.
PubMed Abstract available

September 2020

LORSCHEIDER J, Benkert P, Lienert C, Hanni P, et al
Comparative analysis of dimethyl fumarate and fingolimod in relapsing-remitting multiple sclerosis.
J Neurol. 2020 Sep 24. pii: 10.1007/s00415-020-10226.
PubMed Abstract available

MONSCHEIN T, Salhofer-Polanyi S, Altmann P, Zrzavy T, et al
Should I stop or should I go on? Disease modifying therapy after the first clinical episode of multiple sclerosis.
J Neurol. 2020 Sep 14. pii: 10.1007/s00415-020-10074.
PubMed Abstract available

LEJEUNE F, Chatton A, Laplaud DA, Le Page E, et al
SMILE: a predictive model for Scoring the severity of relapses in MultIple scLErosis.
J Neurol. 2020 Sep 9. pii: 10.1007/s00415-020-10154.
PubMed Abstract available

LO LMP, Taylor BV, Winzenberg T, Palmer AJ, et al
Change and onset-type differences in the prevalence of comorbidities in people with multiple sclerosis.
J Neurol. 2020 Sep 3. pii: 10.1007/s00415-020-10194.
PubMed Abstract available

LO LMP, Taylor BV, Winzenberg T, Palmer AJ, et al
Estimating the relative contribution of comorbidities in predicting health-related quality of life of people with multiple sclerosis.
J Neurol. 2020 Sep 2. pii: 10.1007/s00415-020-10195.
PubMed Abstract available

LO LMP, Taylor BV, Winzenberg T, Palmer AJ, et al
Comorbidities contribute substantially to the severity of common multiple sclerosis symptoms.
J Neurol. 2020 Sep 2. pii: 10.1007/s00415-020-10192.
PubMed Abstract available

FERNANDEZ-DOMINGUEZ J, Ameijide-Sanluis E, Garcia-Cabo C, Garcia-Rodriguez R, et al
Miller-Fisher-like syndrome related to SARS-CoV-2 infection (COVID 19).
J Neurol. 2020;267:2495-2496.
PubMed

August 2020

MANTERO V, Baroncini D, Balgera R, Guaschino C, et al
Mild COVID-19 infection in a group of teriflunomide-treated patients with multiple sclerosis.
J Neurol. 2020 Aug 31. pii: 10.1007/s00415-020-10196.
PubMed

ZHANG J, Chen MJ, Zhao GX, Li HF, et al
Common genetic variants in PRRC2A are associated with both neuromyelitis optica spectrum disorder and multiple sclerosis in Han Chinese population.
J Neurol. 2020 Aug 29. pii: 10.1007/s00415-020-10184.
PubMed Abstract available

ABU-RUMEILEH S, Abdelhak A, Foschi M, Tumani H, et al
Guillain-Barre syndrome spectrum associated with COVID-19: an up-to-date systematic review of 73 cases.
J Neurol. 2020 Aug 25. pii: 10.1007/s00415-020-10124.
PubMed Abstract available

CHIARAVALLOTI ND, Amato MP, Brichetto G, Chataway J, et al
The emotional impact of the COVID-19 pandemic on individuals with progressive multiple sclerosis.
J Neurol. 2020 Aug 19. pii: 10.1007/s00415-020-10160.
PubMed Abstract available

VICINI R, Brugger D, Abegg M, Salmen A, et al
Differences in morphology and visual function of myelin oligodendrocyte glycoprotein antibody and multiple sclerosis associated optic neuritis.
J Neurol. 2020 Aug 12. pii: 10.1007/s00415-020-10097.
PubMed Abstract available

PELEA T, Reuter U, Schmidt C, Laubinger R, et al
SARS-CoV-2 associated Guillain-Barre syndrome.
J Neurol. 2020 Aug 8. pii: 10.1007/s00415-020-10133.
PubMed Abstract available

ASHTON K, Fuchs TA, Oship D, Zivadinov R, et al
Diagnosis of depression in multiple sclerosis is predicted by frontal-parietal white matter tract disruption.
J Neurol. 2020 Aug 4. pii: 10.1007/s00415-020-10110.
PubMed Abstract available

MARINI A, Vogrig A, Bax F, Pellitteri G, et al
Reply to "GuillainBarre syndrome in the COVID19 era another occasional cluster?": Insights from two distinct clusters of Guillain-Barre syndrome detected in Europe in the COVID-19 era.
J Neurol. 2020 Aug 4. pii: 10.1007/s00415-020-10006.
PubMed

MUNZ M, Wessendorf S, Koretsis G, Tewald F, et al
Acute transverse myelitis after COVID-19 pneumonia.
J Neurol. 2020;267:2196-2197.
PubMed

July 2020

YUAN S, Xiong Y, Larsson SC
An atlas on risk factors for multiple sclerosis: a Mendelian randomization study.
J Neurol. 2020 Jul 29. pii: 10.1007/s00415-020-10119.
PubMed Abstract available

ACHIRON A, Ben-David A, Gurevich M, Magalashvili D, et al
Parity and disability progression in relapsing-remitting multiple sclerosis.
J Neurol. 2020 Jul 28. pii: 10.1007/s00415-020-10093.
PubMed Abstract available

CAPUANO R, Altieri M, Bisecco A, d'Ambrosio A, et al
Psychological consequences of COVID-19 pandemic in Italian MS patients: signs of resilience?
J Neurol. 2020 Jul 28. pii: 10.1007/s00415-020-10099.
PubMed Abstract available

HAUER L, Perneczky J, Sellner J
A global view of comorbidity in multiple sclerosis: a systematic review with a focus on regional differences, methodology, and clinical implications.
J Neurol. 2020 Jul 27. pii: 10.1007/s00415-020-10107.
PubMed Abstract available

EVA N, Adam K, Tomas N, Martin V, et al
Spatial navigation in early multiple sclerosis: a neglected cognitive marker of the disease?
J Neurol. 2020 Jul 22. pii: 10.1007/s00415-020-10079.
PubMed Abstract available

KALRON A, Menascu S, Hoffmann C, Achiron A, et al
The importance of physical activity to preserve hippocampal volume in people with multiple sclerosis: a structural MRI study.
J Neurol. 2020 Jul 22. pii: 10.1007/s00415-020-10085.
PubMed Abstract available

LI V, Panicker JN, Haslam C, Chataway J, et al
Use of a symptom-based questionnaire to screen for the presence of significant voiding dysfunction in patients with multiple sclerosis and lower urinary tract symptoms: a pilot study.
J Neurol. 2020 Jul 16. pii: 10.1007/s00415-020-10068.
PubMed Abstract available

MATEEN FJ, Rezaei S, Alakel N, Gazdag B, et al
Impact of COVID-19 on U.S. and Canadian neurologists' therapeutic approach to multiple sclerosis: a survey of knowledge, attitudes, and practices.
J Neurol. 2020 Jul 7. pii: 10.1007/s00415-020-10045.
PubMed Abstract available

DE SITTER A, Verhoeven T, Burggraaff J, Liu Y, et al
Reduced accuracy of MRI deep grey matter segmentation in multiple sclerosis: an evaluation of four automated methods against manual reference segmentations in a multi-center cohort.
J Neurol. 2020 Jul 3. pii: 10.1007/s00415-020-10023.
PubMed Abstract available

KAMINSKY AL, Omorou AY, Soudant M, Pittion-Vouyovitch S, et al
Discontinuation of disease-modifying treatments for multiple sclerosis in patients aged over 50 with disease Inactivity.
J Neurol. 2020 Jul 2. pii: 10.1007/s00415-020-10029.
PubMed Abstract available

RICCITELLI GC, Pagani E, Meani A, Valsasina P, et al
Cognitive impairment in benign multiple sclerosis: a multiparametric structural and functional MRI study.
J Neurol. 2020 Jul 2. pii: 10.1007/s00415-020-10025.
PubMed Abstract available

PFEFFERKORN T, Dabitz R, von Wernitz-Keibel T, Aufenanger J, et al
Acute polyradiculoneuritis with locked-in syndrome in a patient with Covid-19.
J Neurol. 2020;267:1883-1884.
PubMed

BIEN CG, Bien CI, Dogan Onugoren M, De Simoni D, et al
Routine diagnostics for neural antibodies, clinical correlates, treatment and functional outcome.
J Neurol. 2020;267:2101-2114.
PubMed Abstract available

MUNIZ-CASTRILLO S, Ambati A, Dubois V, Vogrig A, et al
Primary DQ effect in the association between HLA and neurological syndromes with anti-GAD65 antibodies.
J Neurol. 2020;267:1906-1911.
PubMed Abstract available

June 2020

BERCIANO J
Axonal degeneration in Guillain-Barre syndrome: a reappraisal.
J Neurol. 2020 Jun 30. pii: 10.1007/s00415-020-10034.
PubMed Abstract available

MANTERO V, Abate L, Basilico P, Balgera R, et al
COVID-19 in dimethyl fumarate-treated patients with multiple sclerosis.
J Neurol. 2020 Jun 25. pii: 10.1007/s00415-020-10015.
PubMed

TATU L, Nono S, Gracio S, Kocer S, et al
Guillain-Barre syndrome in the COVID-19 era: another occasional cluster?
J Neurol. 2020 Jun 23. pii: 10.1007/s00415-020-10005.
PubMed

VAN FAALS NL, Dekker I, Balk LJ, Moraal B, et al
Clinico-radiological dissociation of disease activity in MS patients: frequency and clinical relevance.
J Neurol. 2020 Jun 20. pii: 10.1007/s00415-020-09991.
PubMed Abstract available

KOLANKO M, Win Z, Patel N, Malik O, et al
Using amyloid PET imaging to diagnose Alzheimer's disease in patients with multiple sclerosis.
J Neurol. 2020 Jun 18. pii: 10.1007/s00415-020-09969.
PubMed Abstract available

GRANBERG T, Moridi T, Brand JS, Neumann S, et al
Enlarged perivascular spaces in multiple sclerosis on magnetic resonance imaging: a systematic review and meta-analysis.
J Neurol. 2020 Jun 13. pii: 10.1007/s00415-020-09971.
PubMed Abstract available

VANDEBERGH M, Goris A
Smoking and multiple sclerosis risk: a Mendelian randomization study.
J Neurol. 2020 Jun 11. pii: 10.1007/s00415-020-09980.
PubMed Abstract available

LEHMANN AI, Rodgers S, Kamm CP, Mettler M, et al
Factors associated with employment and expected work retention among persons with multiple sclerosis: findings of a cross-sectional citizen science study.
J Neurol. 2020 Jun 11. pii: 10.1007/s00415-020-09973.
PubMed Abstract available

FERRAZZANO G, Crisafulli SG, Baione V, Tartaglia M, et al
Early diagnosis of secondary progressive multiple sclerosis: focus on fluid and neurophysiological biomarkers.
J Neurol. 2020 Jun 5. pii: 10.1007/s00415-020-09964.
PubMed Abstract available

WELLER D, Filli L, Meyer C, Lorincz L, et al
Impaired speed-dependent modulation of the gait pattern in multiple sclerosis.
J Neurol. 2020 Jun 4. pii: 10.1007/s00415-020-09965.
PubMed Abstract available

MAGHZI AH, Houtchens MK, Preziosa P, Ionete C, et al
COVID-19 in teriflunomide-treated patients with multiple sclerosis.
J Neurol. 2020 Jun 3. pii: 10.1007/s00415-020-09944.
PubMed Abstract available

PATTI F, Zimatore GB, Brescia Morra V, Aguglia U, et al
Administration of subcutaneous interferon beta 1a in the evening: data from RELIEF study.
J Neurol. 2020;267:1812-1823.
PubMed Abstract available

MIAO A, Liu Q, Li Z, Liu W, et al
Altered cerebral blood flow in patients with anti-NMDAR encephalitis.
J Neurol. 2020;267:1760-1773.
PubMed Abstract available

CAROTENUTO A, Costabile T, De Lucia M, Moccia M, et al
Predictors of Nabiximols (Sativex((R))) discontinuation over long-term follow-up: a real-life study.
J Neurol. 2020;267:1737-1743.
PubMed Abstract available

LOOS J, Pfeuffer S, Pape K, Ruck T, et al
MOG encephalomyelitis: distinct clinical, MRI and CSF features in patients with longitudinal extensive transverse myelitis as first clinical presentation.
J Neurol. 2020;267:1632-1642.
PubMed Abstract available

May 2020

TOMASSINI V, Sinclair A, Sawlani V, Overell J, et al
Diagnosis and management of multiple sclerosis: MRI in clinical practice.
J Neurol. 2020 May 29. pii: 10.1007/s00415-020-09930.
PubMed Abstract available

ANGELINI L, Hodgkinson W, Smith C, Dodd JM, et al
Wearable sensors can reliably quantify gait alterations associated with disability in people with progressive multiple sclerosis in a clinical setting.
J Neurol. 2020 May 28. pii: 10.1007/s00415-020-09928.
PubMed Abstract available

SIVAKOLUNDU DK, West KL, Zuppichini MD, Wilson A, et al
BOLD signal within and around white matter lesions distinguishes multiple sclerosis and non-specific white matter disease: a three-dimensional approach.
J Neurol. 2020 May 28. pii: 10.1007/s00415-020-09923.
PubMed Abstract available

MOHN N, Saker F, Bonda V, Respondek G, et al
Mild COVID-19 symptoms despite treatment with teriflunomide and high-dose methylprednisolone due to multiple sclerosis relapse.
J Neurol. 2020 May 28. pii: 10.1007/s00415-020-09921.
PubMed

RIVA N, Russo T, Falzone YM, Strollo M, et al
Post-infectious Guillain-Barre syndrome related to SARS-CoV-2 infection: a case report.
J Neurol. 2020 May 26. pii: 10.1007/s00415-020-09907.
PubMed

GOLD R, Radue EW, Giovannoni G, Selmaj K, et al
Long-term safety and efficacy of daclizumab beta in relapsing-remitting multiple sclerosis: 6-year results from the SELECTED open-label extension study.
J Neurol. 2020 May 25. pii: 10.1007/s00415-020-09835.
PubMed Abstract available

WILLIAMS T, Zetterberg H, Chataway J
Neurofilaments in progressive multiple sclerosis: a systematic review.
J Neurol. 2020 May 23. pii: 10.1007/s00415-020-09917.
PubMed Abstract available

MORRIS JK, Lopez-Leon S, Geissbuhler Y, Sabido M, et al
A systematic review and meta-analyses of pregnancy and fetal outcomes in women with multiple sclerosis: a contribution from the IMI2 ConcePTION project.
J Neurol. 2020 May 22. pii: 10.1007/s00415-020-09913.
PubMed Abstract available

GIGLI GL, Bax F, Marini A, Pellitteri G, et al
Guillain-Barre syndrome in the COVID-19 era: just an occasional cluster?
J Neurol. 2020 May 19. pii: 10.1007/s00415-020-09911.
PubMed

TSANTES E, Curti E, Ganazzoli C, Puci F, et al
The contribution of enhancing lesions in monitoring multiple sclerosis treatment: is gadolinium always necessary?
J Neurol. 2020 May 12. pii: 10.1007/s00415-020-09894.
PubMed Abstract available

KIM JG, Lee SU, Lee CN, Yu SW, et al
Bilateral vestibulopathy as an early manifestation of systemic lupus erythematosus.
J Neurol. 2020 May 11. pii: 10.1007/s00415-020-09876.
PubMed

KOCH MW, Mostert J, Greenfield J, Liu WQ, et al
Gadolinium enhancement on cranial MRI in multiple sclerosis is age dependent.
J Neurol. 2020 May 9. pii: 10.1007/s00415-020-09895.
PubMed Abstract available

DING J, Ren K, Wu J, Li H, et al
Overlapping syndrome of MOG-IgG-associated disease and autoimmune GFAP astrocytopathy.
J Neurol. 2020 May 7. pii: 10.1007/s00415-020-09869.
PubMed Abstract available

COLOMBO C, Confalonieri P, Rovaris M, La Mantia L, et al
The IN-DEEP project "INtegrating and Deriving Evidence, Experiences, Preferences": a web information model on magnetic resonance imaging for people with multiple sclerosis.
J Neurol. 2020 May 2. pii: 10.1007/s00415-020-09864.
PubMed Abstract available

BUKHARI W, Clarke L, O'Gorman C, Khalilidehkordi E, et al
The clinical profile of NMOSD in Australia and New Zealand.
J Neurol. 2020;267:1431-1443.
PubMed Abstract available

MOLONEY PB, Hutchinson S, Heskin J, Mulcahy F, et al
Possible N-methyl-D-aspartate receptor antibody-mediated encephalitis in the setting of HIV cerebrospinal fluid escape.
J Neurol. 2020;267:1348-1352.
PubMed Abstract available

CARNERO CONTENTTI E, Daccach Marques V, Soto de Castillo I, Tkachuk V, et al
Clinical features and prognosis of late-onset neuromyelitis optica spectrum disorders in a Latin American cohort.
J Neurol. 2020;267:1260-1268.
PubMed Abstract available

WENDEBOURG MJ, Nagy S, Derfuss T, Parmar K, et al
Magnetic resonance imaging in immune-mediated myelopathies.
J Neurol. 2020;267:1233-1244.
PubMed Abstract available

April 2020

CHEN MH, Wylie GR, Sandroff BM, Dacosta-Aguayo R, et al
Neural mechanisms underlying state mental fatigue in multiple sclerosis: a pilot study.
J Neurol. 2020 Apr 29. pii: 10.1007/s00415-020-09853.
PubMed Abstract available

SABIN J, Urtiaga S, Pilo B, Thuissard I, et al
Tolerability and safety of dimethyl fumarate in relapsing multiple sclerosis: a prospective observational multicenter study in a real-life Spanish population.
J Neurol. 2020 Apr 29. pii: 10.1007/s00415-020-09848.
PubMed Abstract available

MATEEN FJ, Vogel AC, Kaplan TB, Hotan GC, et al
Light therapy for multiple sclerosis-associated fatigue: a randomized, controlled phase II trial.
J Neurol. 2020 Apr 24. pii: 10.1007/s00415-020-09845.
PubMed Abstract available

PADRONI M, Mastrangelo V, Asioli GM, Pavolucci L, et al
Guillain-Barre syndrome following COVID-19: new infection, old complication?
J Neurol. 2020 Apr 24. pii: 10.1007/s00415-020-09849.
PubMed

MISICKA E, Sept C, Briggs FBS
Predicting onset of secondary-progressive multiple sclerosis using genetic and non-genetic factors.
J Neurol. 2020 Apr 24. pii: 10.1007/s00415-020-09850.
PubMed Abstract available

GIBSON LL, McKeever A, Cullen AE, Nicholson TR, et al
Neuronal surface autoantibodies in dementia: a systematic review and meta-analysis.
J Neurol. 2020 Apr 18. pii: 10.1007/s00415-020-09825.
PubMed Abstract available

WILLIS MD, Robertson NP
Multiple sclerosis and the risk of infection: considerations in the threat of the novel coronavirus, COVID-19/SARS-CoV-2.
J Neurol. 2020 Apr 17. pii: 10.1007/s00415-020-09822.
PubMed

MATTIOLI F, Bellomi F, Stampatori C, Mariotto S, et al
Longitudinal serum neurofilament light chain (sNfL) concentration relates to cognitive function in multiple sclerosis patients.
J Neurol. 2020 Apr 15. pii: 10.1007/s00415-020-09832.
PubMed Abstract available

TANG L, Huang Q, Qin Z, Tang X, et al
Distinguish CIDP with autoantibody from that without autoantibody: pathogenesis, histopathology, and clinical features.
J Neurol. 2020 Apr 7. pii: 10.1007/s00415-020-09823.
PubMed Abstract available

GUGER M, Enzinger C, Leutmezer F, Kraus J, et al
Oral therapies for treatment of relapsing-remitting multiple sclerosis in Austria: a 2-year comparison using an inverse probability weighting method.
J Neurol. 2020 Apr 3. pii: 10.1007/s00415-020-09811.
PubMed Abstract available

ZHANG W, Cui L, Zhang Y, Wang W, et al
Questioning the existence of monophasic neuromyelitis optica spectrum disorder by defining a novel long-term relapse-free form from a large Chinese population.
J Neurol. 2020;267:1197-1205.
PubMed Abstract available

BOYKO M, Au KLK, Casault C, de Robles P, et al
Systematic review of the clinical spectrum of CASPR2 antibody syndrome.
J Neurol. 2020;267:1137-1146.
PubMed Abstract available

SHI Z, Du Q, Chen H, Zhang Y, et al
Effects of immunotherapies and prognostic predictors in neuromyelitis optica spectrum disorder: a prospective cohort study.
J Neurol. 2020;267:913-924.
PubMed Abstract available

March 2020

CAROTENUTO A, Wilson H, Giordano B, Caminiti SP, et al
Impaired connectivity within neuromodulatory networks in multiple sclerosis and clinical implications.
J Neurol. 2020 Mar 26. pii: 10.1007/s00415-020-09806.
PubMed Abstract available

VISSING J, Jacob S, Fujita KP, O'Brien F, et al
'Minimal symptom expression' in patients with acetylcholine receptor antibody-positive refractory generalized myasthenia gravis treated with eculizumab.
J Neurol. 2020 Mar 18. pii: 10.1007/s00415-020-09770.
PubMed Abstract available

SHEMA-SHIRATZKY S, Hillel I, Mirelman A, Regev K, et al
A wearable sensor identifies alterations in community ambulation in multiple sclerosis: contributors to real-world gait quality and physical activity.
J Neurol. 2020 Mar 12. pii: 10.1007/s00415-020-09759.
PubMed Abstract available

GAVRILOV YV, Alekseeva TM, Kreis OA, Valko PO, et al
Depression in myasthenia gravis: a heterogeneous and intriguing entity.
J Neurol. 2020 Mar 5. pii: 10.1007/s00415-020-09767.
PubMed Abstract available

SHANG P, Zhu M, Wang Y, Zheng X, et al
Axonal variants of Guillain-Barre syndrome: an update.
J Neurol. 2020 Mar 5. pii: 10.1007/s00415-020-09742.
PubMed Abstract available

MARGONI M, Franciotta S, Poggiali D, Riccardi A, et al
Cerebellar gray matter lesions are common in pediatric multiple sclerosis at clinical onset.
J Neurol. 2020 Mar 5. pii: 10.1007/s00415-020-09776.
PubMed Abstract available

ZUBER P, Tsagkas C, Papadopoulou A, Gaetano L, et al
Efficacy of inpatient personalized multidisciplinary rehabilitation in multiple sclerosis: behavioural and functional imaging results.
J Neurol. 2020 Mar 2. pii: 10.1007/s00415-020-09768.
PubMed Abstract available

BERARDO A, Emmanuele V, Vargas W, Tanji K, et al
Leber hereditary optic neuropathy plus dystonia, and transverse myelitis due to double mutations in MT-ND4 and MT-ND6.
J Neurol. 2020;267:823-829.
PubMed Abstract available

GIANNOCCARO MP, Di Stasi V, Zanesini C, Donadio V, et al
Sensitivity and specificity of single-fibre EMG in the diagnosis of ocular myasthenia varies accordingly to clinical presentation.
J Neurol. 2020;267:739-745.
PubMed Abstract available

HAMAGUCHI M, Suzuki K, Fujita H, Uzuka T, et al
Successful treatment of non-HIV progressive multifocal leukoencephalopathy: case report and literature review.
J Neurol. 2020;267:731-738.
PubMed Abstract available

February 2020

HELLWIG K, Geissbuehler Y, Sabido M, Popescu C, et al
Pregnancy outcomes in interferon-beta-exposed patients with multiple sclerosis: results from the European Interferon-beta Pregnancy Registry.
J Neurol. 2020 Feb 26. pii: 10.1007/s00415-020-09762.
PubMed Abstract available

MAGON S, Tsagkas C, Gaetano L, Patel R, et al
Volume loss in the deep gray matter and thalamic subnuclei: a longitudinal study on disability progression in multiple sclerosis.
J Neurol. 2020 Feb 10. pii: 10.1007/s00415-020-09740.
PubMed Abstract available

SCHWEITZER F, Laurent S, Fink GR, Barnett MH, et al
Effects of disease-modifying therapy on peripheral leukocytes in patients with multiple sclerosis.
J Neurol. 2020 Feb 8. pii: 10.1007/s00415-019-09690.
PubMed Abstract available

KATSARI M, Kasselimis DS, Giogkaraki E, Breza M, et al
A longitudinal study of cognitive function in multiple sclerosis: is decline inevitable?
J Neurol. 2020 Feb 1. pii: 10.1007/s00415-020-09720.
PubMed Abstract available

TANG MH, Mathis S, Duffau P, Cazenave P, et al
Prognostic factor of poor outcome in anti-MAG neuropathy: clinical and electrophysiological analysis of a French Cohort.
J Neurol. 2020;267:561-571.
PubMed Abstract available

SCHEIBE F, Ostendorf L, Reincke SM, Pruss H, et al
Daratumumab treatment for therapy-refractory anti-CASPR2 encephalitis.
J Neurol. 2020;267:317-323.
PubMed Abstract available

January 2020

NESS NH, Schriefer D, Haase R, Ettle B, et al
Correction to: Differentiating societal costs of disability worsening in multiple sclerosis.
J Neurol. 2020 Jan 16. pii: 10.1007/s00415-019-09694.
PubMed Abstract available

SHAH VV, McNames J, Mancini M, Carlson-Kuhta P, et al
Quantity and quality of gait and turning in people with multiple sclerosis, Parkinson's disease and matched controls during daily living.
J Neurol. 2020 Jan 11. pii: 10.1007/s00415-020-09696.
PubMed Abstract available

FREEDMAN MS, Brod S, Singer BA, Cohen BA, et al
Clinical and MRI efficacy of sc IFN beta-1a tiw in patients with relapsing MS appearing to transition to secondary progressive MS: post hoc analyses of PRISMS and SPECTRIMS.
J Neurol. 2020;267:64-75.
PubMed Abstract available

December 2019

NESS NH, Schriefer D, Haase R, Ettle B, et al
Differentiating societal costs of disability worsening in multiple sclerosis.
J Neurol. 2019 Dec 17. pii: 10.1007/s00415-019-09676.
PubMed Abstract available

HEDSTROM AK, Olsson T, Kockum I, Hillert J, et al
Low sun exposure increases multiple sclerosis risk both directly and indirectly.
J Neurol. 2019 Dec 17. pii: 10.1007/s00415-019-09677.
PubMed Abstract available

RATH J, Brunner I, Tomschik M, Zulehner G, et al
Frequency and clinical features of treatment-refractory myasthenia gravis.
J Neurol. 2019 Dec 11. pii: 10.1007/s00415-019-09667.
PubMed Abstract available

DAVDA N, Tallantyre E, Robertson NP
Early MRI predictors of prognosis in multiple sclerosis.
J Neurol. 2019;266:3171-3173.
PubMed

November 2019

LIN WS, Wang HP, Chen HM, Lin JW, et al
Epidemiology of pediatric multiple sclerosis, neuromyelitis optica, and optic neuritis in Taiwan.
J Neurol. 2019 Nov 28. pii: 10.1007/s00415-019-09647.
PubMed Abstract available

TAVAZZI E, Bergsland N, Kuhle J, Jakimovski D, et al
A multimodal approach to assess the validity of atrophied T2-lesion volume as an MRI marker of disease progression in multiple sclerosis.
J Neurol. 2019 Nov 25. pii: 10.1007/s00415-019-09643.
PubMed Abstract available

SIERRA MORALES F, Koralnik IJ, Gautam S, Samaan S, et al
Correction to: Risk factors for lymphopenia in patients with relapsing-remitting multiple sclerosis treated with dimethyl fumarate.
J Neurol. 2019 Nov 23. pii: 10.1007/s00415-019-09626.
PubMed Abstract available

BOURQUE PR, Brooks J, Warman-Chardon J, Breiner A, et al
Cerebrospinal fluid total protein in Guillain-Barre syndrome variants: correlations with clinical category, severity, and electrophysiology.
J Neurol. 2019 Nov 16. pii: 10.1007/s00415-019-09634.
PubMed Abstract available

GRUTER T, Ott A, Meyer W, Jarius S, et al
Effects of IVIg treatment on autoantibody testing in neurological patients: marked reduction in sensitivity by reliable specificity.
J Neurol. 2019 Nov 14. pii: 10.1007/s00415-019-09614.
PubMed Abstract available

PROSPERINI L, Cortese A, Lucchini M, Boffa L, et al
Exit strategies for "needle fatigue" in multiple sclerosis: a propensity score-matched comparison study.
J Neurol. 2019 Nov 13. pii: 10.1007/s00415-019-09625.
PubMed Abstract available

GOMEZ-FIGUEROA E, Garcia-Trejo S, Bazan-Rodriguez L, Cervantes-Uribe R, et al
Intravenous cyclophosphamide monthly pulses in refractory myasthenia gravis.
J Neurol. 2019 Nov 12. pii: 10.1007/s00415-019-09622.
PubMed Abstract available

LECLER A, Bouzad C, Deschamps R, Maizeroi F, et al
Optimizing 3D FLAIR to detect MS lesions: pushing past factory settings for precise results.
J Neurol. 2019;266:2786-2795.
PubMed Abstract available

HERRAETS IJT, Bakers JNE, van Eijk RPA, Goedee HS, et al
Human immune globulin 10% with recombinant human hyaluronidase in multifocal motor neuropathy.
J Neurol. 2019;266:2734-2742.
PubMed Abstract available

October 2019

GIORDANO A, Fazio R, Gelibter S, Minicucci F, et al
Diagnosing autoimmune encephalitis in a real-world single-centre setting.
J Neurol. 2019 Oct 30. pii: 10.1007/s00415-019-09607.
PubMed Abstract available

MIRAFZAL S, Goujon A, Deschamps R, Zuber K, et al
3D PSIR MRI at 3 Tesla improves detection of spinal cord lesions in multiple sclerosis.
J Neurol. 2019 Oct 26. pii: 10.1007/s00415-019-09591.
PubMed Abstract available

RAMANATHAN S, Al-Diwani A, Waters P, Irani SR, et al
The autoantibody-mediated encephalitides: from clinical observations to molecular pathogenesis.
J Neurol. 2019 Oct 26. pii: 10.1007/s00415-019-09590.
PubMed Abstract available

FUJIMORI J, Fujihara K, Ogawa R, Baba T, et al
Patterns of regional brain volume loss in multiple sclerosis: a cluster analysis.
J Neurol. 2019 Oct 25. pii: 10.1007/s00415-019-09595.
PubMed Abstract available

PAPATHANASIOU A, Tanasescu R, Davis J, Rocha MF, et al
MOG-IgG-associated demyelination: focus on atypical features, brain histopathology and concomitant autoimmunity.
J Neurol. 2019 Oct 22. pii: 10.1007/s00415-019-09586.
PubMed Abstract available

CHAMBERLAIN JL, Huda S, Whittam DH, Matiello M, et al
Correction to: Role of complement and potential of complement inhibitors in myasthenia gravis and neuromyelitis optica spectrum disorders: a brief review.
J Neurol. 2019 Oct 17. pii: 10.1007/s00415-019-09568.
PubMed Abstract available

SINNECKER T, Ruberte E, Schadelin S, Canova V, et al
New and enlarging white matter lesions adjacent to the ventricle system and thalamic atrophy are independently associated with lateral ventricular enlargement in multiple sclerosis.
J Neurol. 2019 Oct 14. pii: 10.1007/s00415-019-09565.
PubMed Abstract available

KAMM CP, Barin L, Gobbi C, Pot C, et al
Factors influencing patient satisfaction with the first diagnostic consultation in multiple sclerosis: a Swiss Multiple Sclerosis Registry (SMSR) study.
J Neurol. 2019 Oct 8. pii: 10.1007/s00415-019-09563.
PubMed Abstract available

ROMEO MAL, Garassino MC, Moiola L, Galli G, et al
Multiple sclerosis associated with pembrolizumab in a patient with non-small cell lung cancer.
J Neurol. 2019 Oct 4. pii: 10.1007/s00415-019-09562.
PubMed

MORALES FS, Koralnik IJ, Gautam S, Samaan S, et al
Risk factors for lymphopenia in patients with relapsing-remitting multiple sclerosis treated with dimethyl fumarate.
J Neurol. 2019 Oct 3. pii: 10.1007/s00415-019-09557.
PubMed Abstract available

BUDHRAM A, Mirian A, Le C, Hosseini-Moghaddam SM, et al
Unilateral cortical FLAIR-hyperintense Lesions in Anti-MOG-associated Encephalitis with Seizures (FLAMES): characterization of a distinct clinico-radiographic syndrome.
J Neurol. 2019;266:2481-2487.
PubMed Abstract available

September 2019

MARGONI M, Rinaldi F, Riccardi A, Franciotta S, et al
No evidence of disease activity including cognition (NEDA-3 plus) in naive pediatric multiple sclerosis patients treated with natalizumab.
J Neurol. 2019 Sep 27. pii: 10.1007/s00415-019-09554.
PubMed Abstract available

PAOLICELLI D, Lucisano G, Manni A, Avolio C, et al
Retrospectively acquired cohort study to evaluate the long-term impact of two different treatment strategies on disability outcomes in patients with relapsing multiple sclerosis (RE.LO.DI.MS): data from the Italian MS Register.
J Neurol. 2019 Sep 18. pii: 10.1007/s00415-019-09531.
PubMed Abstract available

GUGER M, Enzinger C, Leutmezer F, Kraus J, et al
Correction to: Switching from natalizumab to fingolimod treatment in multiple sclerosis: real life data from the Austrian MS Treatment Registry.
J Neurol. 2019 Sep 17. pii: 10.1007/s00415-019-09535.
PubMed Abstract available

GRANELLA F, Tsantes E, Graziuso S, Bazzurri V, et al
Spinal cord lesions are frequently asymptomatic in relapsing-remitting multiple sclerosis: a retrospective MRI survey.
J Neurol. 2019 Sep 7. pii: 10.1007/s00415-019-09526.
PubMed Abstract available

SHEMA-SHIRATZKY S, Gazit E, Sun R, Regev K, et al
Deterioration of specific aspects of gait during the instrumented 6-min walk test among people with multiple sclerosis.
J Neurol. 2019 Sep 6. pii: 10.1007/s00415-019-09500.
PubMed Abstract available

CHAMBERLAIN JL, Huda S, Whittam DH, Matiello M, et al
Role of complement and potential of complement inhibitors in myasthenia gravis and neuromyelitis optica spectrum disorders: a brief review.
J Neurol. 2019 Sep 3. pii: 10.1007/s00415-019-09498.
PubMed Abstract available

CASTLE D, Robertson NP
Alternatives to intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyradiculoneuropathy.
J Neurol. 2019;266:2338-2340.
PubMed

CHOUTEAU R, Combes B, Bannier E, Snoussi H, et al
Joint assessment of brain and spinal cord motor tract damage in patients with early RRMS: predominant impact of spinal cord lesions on motor function.
J Neurol. 2019;266:2294-2303.
PubMed Abstract available

PUMA A, Azulay N, Grecu N, Suply C, et al
Comparison of high-frequency and ultrahigh-frequency probes in chronic inflammatory demyelinating polyneuropathy.
J Neurol. 2019;266:2277-2285.
PubMed Abstract available

August 2019

STORELLI L, Rocca MA, Pantano P, Pagani E, et al
MRI quality control for the Italian Neuroimaging Network Initiative: moving towards big data in multiple sclerosis.
J Neurol. 2019 Aug 17. pii: 10.1007/s00415-019-09509.
PubMed Abstract available

July 2019

INOJOSA H, Proschmann U, Akgun K, Ziemssen T, et al
A focus on secondary progressive multiple sclerosis (SPMS): challenges in diagnosis and definition.
J Neurol. 2019 Jul 30. pii: 10.1007/s00415-019-09489.
PubMed Abstract available

RASTAS C, Sirignano D, Barner A, Bruno-Murtha LA, et al
Legionella infection associated with dimethyl fumarate used for treatment of multiple sclerosis.
J Neurol. 2019 Jul 26. pii: 10.1007/s00415-019-09483.
PubMed

KIMURA K, Okada Y, Fujii C, Komatsu K, et al
Clinical characteristics of autoimmune disorders in the central nervous system associated with myasthenia gravis.
J Neurol. 2019 Jul 24. pii: 10.1007/s00415-019-09461.
PubMed Abstract available

MO XB, Lei SF, Qian QY, Guo YF, et al
Integrative analysis revealed potential causal genetic and epigenetic factors for multiple sclerosis.
J Neurol. 2019 Jul 18. pii: 10.1007/s00415-019-09476.
PubMed Abstract available

MICHAEL G, Christian E, Fritz L, Jorg K, et al
Switching from natalizumab to fingolimod treatment in multiple sclerosis: real life data from the Austrian MS Treatment Registry.
J Neurol. 2019 Jul 16. pii: 10.1007/s00415-019-09464.
PubMed Abstract available

RAIMO S, Trojano L, Gaita M, Spitaleri D, et al
High openness and high extroversion are linked with better time-based prospective memory in multiple sclerosis.
J Neurol. 2019 Jul 16. pii: 10.1007/s00415-019-09460.
PubMed Abstract available

AYRIGNAC X, Rigau V, Lhermitte B, Vincent T, et al
Pathologic and MRI analysis in acute atypical inflammatory demyelinating lesions.
J Neurol. 2019;266:1743-1755.
PubMed Abstract available

TANI H, Nagai K, Hosokawa T, Hata K, et al
Occurrence of cerebral small vessel disease at diagnosis of MPO-ANCA-associated vasculitis.
J Neurol. 2019;266:1708-1715.
PubMed Abstract available

KOGA M, Kishi M, Fukusako T, Ikuta N, et al
Antecedent infections in Fisher syndrome: sources of variation in clinical characteristics.
J Neurol. 2019;266:1655-1662.
PubMed Abstract available

June 2019

BERENGUER-RUIZ L, Gimenez-Martinez J, Palazon-Bru A, Sempere AP, et al
Relapses and obstetric outcomes in women with multiple sclerosis planning pregnancy.
J Neurol. 2019 Jun 29. pii: 10.1007/s00415-019-09450.
PubMed Abstract available

FRAU J, Sacca F, Signori A, Baroncini D, et al
Outcomes after fingolimod to alemtuzumab treatment shift in relapsing-remitting MS patients: a multicentre cohort study.
J Neurol. 2019 Jun 17. pii: 10.1007/s00415-019-09424.
PubMed Abstract available

SPARACO M, Lavorgna L, Bonavita S
Psychiatric disorders in multiple sclerosis.
J Neurol. 2019 Jun 13. pii: 10.1007/s00415-019-09426.
PubMed Abstract available

CUNNIFFE N, Coles A
Promoting remyelination in multiple sclerosis.
J Neurol. 2019 Jun 12. pii: 10.1007/s00415-019-09421.
PubMed Abstract available

KEARNS PKA, Paton M, O'Neill M, Waters C, et al
Regional variation in the incidence rate and sex ratio of multiple sclerosis in Scotland 2010-2017: findings from the Scottish Multiple Sclerosis Register.
J Neurol. 2019 Jun 11. pii: 10.1007/s00415-019-09413.
PubMed Abstract available

SCHUSTER S, Ozga AK, Stellmann JP, Deb-Chatterji M, et al
Relapse rates and long-term outcome in primary angiitis of the central nervous system.
J Neurol. 2019;266:1481-1489.
PubMed Abstract available

May 2019

SODERHOLM J, Yilmaz A, Svenningsson A, Busch K, et al
Lower risk of multiple sclerosis in patients with chronic hepatitis C: a nationwide population-based registry study.
J Neurol. 2019 May 31. pii: 10.1007/s00415-019-09397.
PubMed Abstract available

LI H, Hu F, Zhang Y, Li K, et al
Comparative efficacy and acceptability of disease-modifying therapies in patients with relapsing-remitting multiple sclerosis: a systematic review and network meta-analysis.
J Neurol. 2019 May 25. pii: 10.1007/s00415-019-09395.
PubMed Abstract available

GAETANI L, Salvadori N, Lisetti V, Eusebi P, et al
Cerebrospinal fluid neurofilament light chain tracks cognitive impairment in multiple sclerosis.
J Neurol. 2019 May 25. pii: 10.1007/s00415-019-09398.
PubMed Abstract available

DUDEK MIR, Thies K, Kammenhuber S, Bosel J, et al
HSV-2-encephalitis in a patient with multiple sclerosis treated with ocrelizumab.
J Neurol. 2019 May 21. pii: 10.1007/s00415-019-09391.
PubMed

ALEKSEEVA TM, Kreis OA, Gavrilov YV, Valko PO, et al
Impact of autoimmune comorbidity on fatigue, sleepiness and mood in myasthenia gravis.
J Neurol. 2019 May 21. pii: 10.1007/s00415-019-09374.
PubMed Abstract available

LANGENBRUCH L, Kramer J, Guler S, Moddel G, et al
Seizures and epilepsy in multiple sclerosis: epidemiology and prognosis in a large tertiary referral center.
J Neurol. 2019 May 8. pii: 10.1007/s00415-019-09332.
PubMed Abstract available

PANTAVOU KG, Bagos PG
Season of birth and multiple sclerosis: a systematic review and multivariate meta-analysis.
J Neurol. 2019 May 4. pii: 10.1007/s00415-019-09346.
PubMed Abstract available

ZIFF OJ, Hoskote C, Keddie S, D'Sa S, et al
Frequent central nervous system, pachymeningeal and plexus MRI changes in POEMS syndrome.
J Neurol. 2019;266:1067-1072.
PubMed Abstract available

WYNFORD-THOMAS R, Jacob A, Tomassini V
Neurological update: MOG antibody disease.
J Neurol. 2019;266:1280-1286.
PubMed Abstract available

April 2019

PUST GEA, Pottgen J, Randerath J, Lau S, et al
In search of distinct MS-related fatigue subtypes: results from a multi-cohort analysis in 1.403 MS patients.
J Neurol. 2019 Apr 19. pii: 10.1007/s00415-019-09311.
PubMed Abstract available

HONG Y, Skeie GO, Zisimopoulou P, Karagiorgou K, et al
Retraction Note to: Juvenile-onset myasthenia gravis: autoantibody status, clinical characteristics and genetic polymorphisms.
J Neurol. 2019 Apr 11. pii: 10.1007/s00415-019-09292.
PubMed Abstract available

SPINA E, Topa A, Iodice R, Tozza S, et al
Six-minute walk test is reliable and sensitive in detecting response to therapy in CIDP.
J Neurol. 2019;266:860-865.
PubMed Abstract available

March 2019

SINGH N, Goyal V
Rituximab as induction therapy in refractory myasthenia gravis: 18 month follow-up study.
J Neurol. 2019 Mar 27. pii: 10.1007/s00415-019-09296.
PubMed Abstract available

GAO J, Jones J, Damato EM, Coles A, et al
Acute posterior multifocal placoid pigment epitheliopathy after alemtuzumab treatment for relapsing-remitting multiple sclerosis.
J Neurol. 2019 Mar 20. pii: 10.1007/s00415-019-09288.
PubMed

AL-ANSARI A, Robertson NP
Autoimmune encephalitis: frequency and prognosis.
J Neurol. 2019 Mar 15. pii: 10.1007/s00415-019-09273.
PubMed

FRAU J, Coghe G, Lorefice L, Fenu G, et al
Efficacy and safety of alemtuzumab in a real-life cohort of patients with multiple sclerosis.
J Neurol. 2019 Mar 12. pii: 10.1007/s00415-019-09272.
PubMed Abstract available

NYE CJS, Wagner A, Kousin-Ezewu O, Jones JL, et al
A case of anaphylaxis to alemtuzumab.
J Neurol. 2019;266:780-781.
PubMed

SHAYGANNEJAD V, Fayyazi E, Badihian S, Mirmosayyeb O, et al
Long-term tolerability, safety and efficacy of rituximab in neuromyelitis optica spectrum disorder: a prospective study.
J Neurol. 2019;266:642-650.
PubMed Abstract available

February 2019

TURNER B, Cree BAC, Kappos L, Montalban X, et al
Ocrelizumab efficacy in subgroups of patients with relapsing multiple sclerosis.
J Neurol. 2019 Feb 28. pii: 10.1007/s00415-019-09248.
PubMed Abstract available

RICHTER S, Wagner B, Celius EG
Two cases of diabetes mellitus type 1 after alemtuzumab treatment for multiple sclerosis: another probable secondary autoimmune disease.
J Neurol. 2019 Feb 25. pii: 10.1007/s00415-019-09257.
PubMed

PERSSON R, Lee S, Yood MU, Wagner M, et al
Multi-database study of multiple sclerosis: identification, validation and description of MS patients in two countries.
J Neurol. 2019 Feb 18. pii: 10.1007/s00415-019-09238.
PubMed Abstract available

JAKIMOVSKI D, Weinstock-Guttman B, Gandhi S, Guan Y, et al
Dietary and lifestyle factors in multiple sclerosis progression: results from a 5-year longitudinal MRI study.
J Neurol. 2019 Feb 13. pii: 10.1007/s00415-019-09208.
PubMed Abstract available

MASSA R, Greco G, Testi M, Rastelli E, et al
Thymomatous myasthenia gravis: novel association with HLA DQB1*05:01 and strengthened evidence of high clinical and serological severity.
J Neurol. 2019 Feb 11. pii: 10.1007/s00415-019-09225.
PubMed Abstract available

BLATTNER MS, de Bruin GS, Bucelli RC, Day GS, et al
Sleep disturbances are common in patients with autoimmune encephalitis.
J Neurol. 2019 Feb 11. pii: 10.1007/s00415-019-09230.
PubMed Abstract available

LEBRUN-FRENAY C, Moulignier A, Pierrot-Deseilligny C, Benrabah R, et al
Five-year outcome in the copaxone observatory: a nationwide cohort of patients with multiple sclerosis starting treatment with glatiramer acetate in France.
J Neurol. 2019 Feb 7. pii: 10.1007/s00415-019-09211.
PubMed Abstract available

KIM SW, Choi YC, Kim SM, Shim HS, et al
Effect of thymectomy in elderly patients with non-thymomatous generalized myasthenia gravis.
J Neurol. 2019 Feb 6. pii: 10.1007/s00415-019-09222.
PubMed Abstract available

GAMRAOUI S, Mathey G, Debouverie M, Malaplate C, et al
High performance of cerebrospinal fluid immunoglobulin G analysis for diagnosis of multiple sclerosis.
J Neurol. 2019 Feb 1. pii: 10.1007/s00415-019-09212.
PubMed Abstract available

LAURIDO-SOTO O, Brier MR, Simon LE, McCullough A, et al
Patient characteristics and outcome associations in AMPA receptor encephalitis.
J Neurol. 2019;266:450-460.
PubMed Abstract available

RAJABALLY YA, Afzal S
Clinical and economic comparison of an individualised immunoglobulin protocol vs. standard dosing for chronic inflammatory demyelinating polyneuropathy.
J Neurol. 2019;266:461-467.
PubMed Abstract available

FISSE AL, Pitarokoili K, Motte J, Gamber D, et al
Nerve echogenicity and intranerve CSA variability in high-resolution nerve ultrasound (HRUS) in chronic inflammatory demyelinating polyneuropathy (CIDP).
J Neurol. 2019;266:468-475.
PubMed Abstract available

D'AMICO E, Zanghi A, Sciandra M, Borriello G, et al
Discontinuation of teriflunomide and dimethyl fumarate in a large Italian multicentre population: a 24-month real-world experience.
J Neurol. 2019;266:411-416.
PubMed Abstract available

CHALMER TA, Kalincik T, Laursen B, Sorensen PS, et al
Treatment escalation leads to fewer relapses compared with switching to another moderately effective therapy.
J Neurol. 2019;266:306-315.
PubMed Abstract available

January 2019

ALCALA C, Gascon F, Perez-Miralles F, Dominguez JA, et al
Treatment with alemtuzumab or rituximab after fingolimod withdrawal in relapsing-remitting multiple sclerosis is effective and safe.
J Neurol. 2019 Jan 19. pii: 10.1007/s00415-019-09195.
PubMed Abstract available

LAVORGNA L, Esposito S, Lanzillo R, Sparaco M, et al
Factors interfering with parenthood decision-making in an Italian sample of people with multiple sclerosis: an exploratory online survey.
J Neurol. 2019 Jan 16. pii: 10.1007/s00415-019-09193.
PubMed Abstract available

TOPAKIAN R, Zimprich F, Iglseder S, Embacher N, et al
High efficacy of rituximab for myasthenia gravis: a comprehensive nationwide study in Austria.
J Neurol. 2019 Jan 16. pii: 10.1007/s00415-019-09191.
PubMed Abstract available

HARTUNG HP, Graf J, Kremer D
Long-term follow-up of multiple sclerosis studies and outcomes from early treatment of clinically isolated syndrome in the BENEFIT 11 study.
J Neurol. 2019 Jan 4. pii: 10.1007/s00415-018-09169.
PubMed Abstract available

PFEUFFER S, Schmidt R, Straeten FA, Pul R, et al
Efficacy and safety of alemtuzumab versus fingolimod in RRMS after natalizumab cessation.
J Neurol. 2019;266:165-173.
PubMed Abstract available

December 2018

SONG J, Westerlind H, McKay KA, Almqvist C, et al
Familial risk of early- and late-onset multiple sclerosis: a Swedish nationwide study.
J Neurol. 2018 Dec 21. pii: 10.1007/s00415-018-9163.
PubMed Abstract available

AL-HAKEM H, Sindrup SH, Andersen H, de la Cour CD, et al
Guillain-Barre syndrome in Denmark: a population-based study on epidemiology, diagnosis and clinical severity.
J Neurol. 2018 Dec 7. pii: 10.1007/s00415-018-9151.
PubMed Abstract available

JOHNEN A, Burkner PC, Landmeyer NC, Ambrosius B, et al
Can we predict cognitive decline after initial diagnosis of multiple sclerosis? Results from the German National early MS cohort (KKNMS).
J Neurol. 2018 Dec 4. pii: 10.1007/s00415-018-9142.
PubMed Abstract available

BRAUNE S, Grimm S, van Hovell P, Freudensprung U, et al
Comparative effectiveness of delayed-release dimethyl fumarate versus interferon, glatiramer acetate, teriflunomide, or fingolimod: results from the German NeuroTransData registry.
J Neurol. 2018;265:2980-2992.
PubMed Abstract available

FALZONE YM, Campagnolo M, Bianco M, Dacci P, et al
Functioning and quality of life in patients with neuropathy associated with anti-MAG antibodies.
J Neurol. 2018;265:2927-2933.
PubMed Abstract available

DORST J, Ludolph AC, Senel M, Tumani H, et al
Short-term and long-term effects of immunoadsorption in refractory chronic inflammatory demyelinating polyneuropathy: a prospective study in 17 patients.
J Neurol. 2018;265:2906-2915.
PubMed Abstract available

November 2018

MEGNA R, Alfano B, Lanzillo R, Costabile T, et al
Brain tissue volumes and relaxation rates in multiple sclerosis: implications for cognitive impairment.
J Neurol. 2018 Nov 29. pii: 10.1007/s00415-018-9139.
PubMed Abstract available

KILJAN S, Meijer KA, Steenwijk MD, Pouwels PJW, et al
Structural network topology relates to tissue properties in multiple sclerosis.
J Neurol. 2018 Nov 22. pii: 10.1007/s00415-018-9130.
PubMed Abstract available

HARDING KE, Robertson NP
New rare genetic variants in multiple sclerosis.
J Neurol. 2018 Nov 20. pii: 10.1007/s00415-018-9128.
PubMed

RIEDERER I, Muhlau M, Hoshi MM, Zimmer C, et al
Detecting optic nerve lesions in clinically isolated syndrome and multiple sclerosis: double-inversion recovery magnetic resonance imaging in comparison with visually evoked potentials.
J Neurol. 2018 Nov 16. pii: 10.1007/s00415-018-9114.
PubMed Abstract available

BAUMGARTNER A, Rauer S, Hottenrott T, Leypoldt F, et al
Admission diagnoses of patients later diagnosed with autoimmune encephalitis.
J Neurol. 2018 Nov 12. pii: 10.1007/s00415-018-9105.
PubMed Abstract available

SAEZ MS, Rojas JI, Lorenzon MV, Sanchez F, et al
Validation of CSF free light chain in diagnosis and prognosis of multiple sclerosis and clinically isolated syndrome: prospective cohort study in Buenos Aires.
J Neurol. 2018 Nov 1. pii: 10.1007/s00415-018-9106.
PubMed Abstract available

STAMPANONI BASSI M, Iezzi E, Landi D, Monteleone F, et al
Delayed treatment of MS is associated with high CSF levels of IL-6 and IL-8 and worse future disease course.
J Neurol. 2018;265:2540-2547.
PubMed Abstract available

October 2018

ELLRICHMANN G, Bolz J, Peschke M, Duscha A, et al
Peripheral CD19(+) B-cell counts and infusion intervals as a surrogate for long-term B-cell depleting therapy in multiple sclerosis and neuromyelitis optica/neuromyelitis optica spectrum disorders.
J Neurol. 2018 Oct 30. pii: 10.1007/s00415-018-9092.
PubMed Abstract available

MCLAUGHLIN L, Clarke L, Khalilidehkordi E, Butzkueven H, et al
Vitamin D for the treatment of multiple sclerosis: a meta-analysis.
J Neurol. 2018 Oct 3. pii: 10.1007/s00415-018-9074.
PubMed Abstract available

TOMMASIN S, De Giglio L, Ruggieri S, Petsas N, et al
Relation between functional connectivity and disability in multiple sclerosis: a non-linear model.
J Neurol. 2018 Oct 1. pii: 10.1007/s00415-018-9075.
PubMed Abstract available

September 2018

PROSPERINI L, Annovazzi P, Boffa L, Buscarinu MC, et al
No evidence of disease activity (NEDA-3) and disability improvement after alemtuzumab treatment for multiple sclerosis: a 36-month real-world study.
J Neurol. 2018 Sep 26. pii: 10.1007/s00415-018-9070.
PubMed Abstract available

TUDOR KI, Eames S, Haslam C, Chataway J, et al
Identifying barriers to help-seeking for sexual dysfunction in multiple sclerosis.
J Neurol. 2018 Sep 19. pii: 10.1007/s00415-018-9064.
PubMed Abstract available

LI F, Hotter B, Swierzy M, Ismail M, et al
Generalization after ocular onset in myasthenia gravis: a case series in Germany.
J Neurol. 2018 Sep 17. pii: 10.1007/s00415-018-9056.
PubMed Abstract available

FAKIH R, Matiello M, Chitnis T, Stankiewicz JM, et al
Efficacy and safety of mycophenolate mofetil in progressive multiple sclerosis patients.
J Neurol. 2018 Sep 10. pii: 10.1007/s00415-018-9050.
PubMed Abstract available

GAETANI L, Prosperini L, Mancini A, Eusebi P, et al
2017 revisions of McDonald criteria shorten the time to diagnosis of multiple sclerosis in clinically isolated syndromes.
J Neurol. 2018 Sep 8. pii: 10.1007/s00415-018-9048.
PubMed Abstract available

LY LT, Kreye J, Jurek B, Leubner J, et al
Affinities of human NMDA receptor autoantibodies: implications for disease mechanisms and clinical diagnostics.
J Neurol. 2018 Sep 5. pii: 10.1007/s00415-018-9042.
PubMed Abstract available

CAMBRON M, Reynders T, Debruyne J, Reyngoudt H, et al
Targeting phosphocreatine metabolism in relapsing-remitting multiple sclerosis: evaluation with brain MRI, (1)H and (31)P MRS, and clinical and cognitive testing.
J Neurol. 2018 Sep 5. pii: 10.1007/s00415-018-9039.
PubMed Abstract available

VAN LIEVERLOO GGA, Peric S, Doneddu PE, Gallia F, et al
Corticosteroids in chronic inflammatory demyelinating polyneuropathy : A retrospective, multicentre study, comparing efficacy and safety of daily prednisolone, pulsed dexamethasone, and pulsed intravenous methylprednisolone.
J Neurol. 2018;265:2052-2059.
PubMed Abstract available

August 2018

FILSER M, Schreiber H, Pottgen J, Ullrich S, et al
The Brief International Cognitive Assessment in Multiple Sclerosis (BICAMS): results from the German validation study.
J Neurol. 2018 Aug 31. pii: 10.1007/s00415-018-9034.
PubMed Abstract available

BABER U, Bouley A, Egnor E, Sloane JA, et al
Anti-JC virus antibody index changes in rituximab-treated multiple sclerosis patients.
J Neurol. 2018 Aug 14. pii: 10.1007/s00415-018-8996.
PubMed Abstract available

ALEKSEEVA TM, Gavrilov YV, Kreis OA, Valko PO, et al
Fatigue in patients with myasthenia gravis.
J Neurol. 2018 Aug 11. pii: 10.1007/s00415-018-8995.
PubMed Abstract available

RUMPF JJ, Dietrich S, Stoppe M, Fricke C, et al
Compromised tDCS-induced facilitation of motor consolidation in patients with multiple sclerosis.
J Neurol. 2018 Aug 6. pii: 10.1007/s00415-018-8993.
PubMed Abstract available

SEITZ CB, Droby A, Zaubitzer L, Kramer J, et al
Discriminative power of intra-retinal layers in early multiple sclerosis using 3D OCT imaging.
J Neurol. 2018 Aug 2. pii: 10.1007/s00415-018-8988.
PubMed Abstract available

MALLUCCI G, Annovazzi P, Miante S, Torri-Clerici V, et al
Two-year real-life efficacy, tolerability and safety of dimethyl fumarate in an Italian multicentre study.
J Neurol. 2018;265:1850-1859.
PubMed Abstract available

CAO D, Guo X, Yuan T, Hao J, et al
Diagnosing chronic inflammatory demyelinating polyradiculoneuropathy with triple stimulation technique.
J Neurol. 2018;265:1916-1921.
PubMed Abstract available

July 2018

FROHLICH K, Winder K, Linker RA, Huhn K, et al
Lesion correlates of secondary paroxysmal dyskinesia in multiple sclerosis.
J Neurol. 2018 Jul 31. pii: 10.1007/s00415-018-8989.
PubMed Abstract available

COCOZZA S, Pontillo G, Russo C, Russo CV, et al
Cerebellum and cognition in progressive MS patients: functional changes beyond atrophy?
J Neurol. 2018 Jul 28. pii: 10.1007/s00415-018-8985.
PubMed Abstract available

BALLOY G, Pelletier J, Suchet L, Lebrun C, et al
Inaugural tumor-like multiple sclerosis: clinical presentation and medium-term outcome in 87 patients.
J Neurol. 2018 Jul 27. pii: 10.1007/s00415-018-8984.
PubMed Abstract available

BARONE S, Caligiuri ME, Valentino P, Cherubini A, et al
Multimodal assessment of normal-appearing corpus callosum is a useful marker of disability in relapsing-remitting multiple sclerosis: an MRI cluster analysis study.
J Neurol. 2018 Jul 26. pii: 10.1007/s00415-018-8980.
PubMed Abstract available

GALGANI S, Prosperini L, Haggiag S, Tortorella C, et al
Early transient asymptomatic neutropenia associated with alemtuzumab treatment in multiple sclerosis: a case report.
J Neurol. 2018 Jul 17. pii: 10.1007/s00415-018-8976.
PubMed

BOST C, Chanson E, Picard G, Meyronet D, et al
Malignant tumors in autoimmune encephalitis with anti-NMDA receptor antibodies.
J Neurol. 2018 Jul 12. pii: 10.1007/s00415-018-8970.
PubMed Abstract available

ALADRO Y, Lopez-Alvarez L, Sanchez-Reyes JM, Hernandez-Tamames JA, et al
Relationship between episodic memory and volume of the brain regions of two functional cortical memory systems in multiple sclerosis.
J Neurol. 2018 Jul 11. pii: 10.1007/s00415-018-8965.
PubMed Abstract available

KALLWEIT U, Bassetti CLA, Oberholzer M, Fronczek R, et al
Coexisting narcolepsy (with and without cataplexy) and multiple sclerosis : Six new cases and a literature review.
J Neurol. 2018 Jul 4. pii: 10.1007/s00415-018-8949.
PubMed Abstract available

June 2018

BAJRAMI A, Pitteri M, Castellaro M, Pizzini F, et al
The effect of fingolimod on focal and diffuse grey matter damage in active MS patients.
J Neurol. 2018 Jun 25. pii: 10.1007/s00415-018-8952.
PubMed Abstract available

MOTTE J, Kneiphof J, Strassburger-Krogias K, Klasing A, et al
Detection of JC virus archetype in cerebrospinal fluid in a MS patient with dimethylfumarate treatment without lymphopenia or signs of PML.
J Neurol. 2018 Jun 15. pii: 10.1007/s00415-018-8931.
PubMed Abstract available

May 2018

MARSHALL I, Thrippleton MJ, Bastin ME, Mollison D, et al
Characterisation of tissue-type metabolic content in secondary progressive multiple sclerosis: a magnetic resonance spectroscopic imaging study.
J Neurol. 2018 May 30. pii: 10.1007/s00415-018-8903.
PubMed Abstract available

WAGNER JN, Schwarz G, Puttinger G, Hengsberger AM, et al
Anti-NMDA receptor encephalitis triggered by epilepsy surgery.
J Neurol. 2018 May 30. pii: 10.1007/s00415-018-8918.
PubMed

YAMAGUCHI H, Sakai K, Goto Y, Yamada M, et al
Autoimmune hepatitis induced by a single injection of interferon-beta 1a in a patient with multiple sclerosis.
J Neurol. 2018 May 29. pii: 10.1007/s00415-018-8912.
PubMed

SANTANGELO G, Bisecco A, Trojano L, Sacco R, et al
Cognitive performance in multiple sclerosis: the contribution of intellectual enrichment and brain MRI measures.
J Neurol. 2018 May 26. pii: 10.1007/s00415-018-8905.
PubMed Abstract available

ALCALA C, Gascon F, Perez-Miralles F, Gil-Perotin S, et al
Efficacy and safety of rituximab in relapsing and progressive multiple sclerosis: a hospital-based study.
J Neurol. 2018 May 21. pii: 10.1007/s00415-018-8899.
PubMed Abstract available

KOCSIK AS, Klein DE, Liedke M, Kaunzner UW, et al
Induction of disease remission with one cycle of alemtuzumab in relapsing-remitting MS.
J Neurol. 2018;265:1226-1229.
PubMed Abstract available

OPFER R, Ostwaldt AC, Walker-Egger C, Manogaran P, et al
Within-patient fluctuation of brain volume estimates from short-term repeated MRI measurements using SIENA/FSL.
J Neurol. 2018;265:1158-1165.
PubMed Abstract available

TALLANTYRE EC, Whittam DH, Jolles S, Paling D, et al
Secondary antibody deficiency: a complication of anti-CD20 therapy for neuroinflammation.
J Neurol. 2018;265:1115-1122.
PubMed Abstract available

April 2018

RASUL T, Frederiksen JL
Link between overweight/obese in children and youngsters and occurrence of multiple sclerosis.
J Neurol. 2018 Apr 26. pii: 10.1007/s00415-018-8869.
PubMed Abstract available

HUHN K, Bayas A, Doerck S, Frank B, et al
Alemtuzumab as rescue therapy in a cohort of 50 relapsing-remitting MS patients with breakthrough disease on fingolimod: a multi-center observational study.
J Neurol. 2018 Apr 25. pii: 10.1007/s00415-018-8871.
PubMed Abstract available

TAVAZZI E, Bergsland N, Cattaneo D, Gervasoni E, et al
Effects of motor rehabilitation on mobility and brain plasticity in multiple sclerosis: a structural and functional MRI study.
J Neurol. 2018 Apr 7. pii: 10.1007/s00415-018-8859.
PubMed Abstract available

CABRE P, Mejdoubi M, Jeannin S, Merle H, et al
Treatment of neuromyelitis optica with rituximab: a 2-year prospective multicenter study.
J Neurol. 2018;265:917-925.
PubMed Abstract available

March 2018

COGHE G, Corona F, Marongiu E, Fenu G, et al
Fatigue, as measured using the Modified Fatigue Impact Scale, is a predictor of processing speed improvement induced by exercise in patients with multiple sclerosis: data from a randomized controlled trial.
J Neurol. 2018 Mar 24. pii: 10.1007/s00415-018-8836.
PubMed Abstract available

NAKKEN O, Lindstrom JC, Holmoy T
Sex ratio in multiple sclerosis mortality over 65 years; an age-period-cohort analysis in Norway.
J Neurol. 2018 Mar 21. pii: 10.1007/s00415-018-8832.
PubMed Abstract available

CERONIE B, Jacobs BM, Baker D, Dubuisson N, et al
Cladribine treatment of multiple sclerosis is associated with depletion of memory B cells.
J Neurol. 2018 Mar 17. pii: 10.1007/s00415-018-8830.
PubMed Abstract available

LANZILLO R, Prosperini L, Gasperini C, Moccia M, et al
A multicentRE observational analysiS of PErsistenCe to Treatment in the new multiple sclerosis era: the RESPECT study.
J Neurol. 2018 Mar 16. pii: 10.1007/s00415-018-8831.
PubMed Abstract available

AOYAMA S, Mori M, Uzawa A, Uchida T, et al
Serum anti-JCV antibody indexes in Japanese patients with multiple sclerosis: elevations along with fingolimod treatment duration.
J Neurol. 2018 Mar 12. pii: 10.1007/s00415-018-8813.
PubMed Abstract available

DEVONSHIRE V, Phillips R, Wass H, Da Roza G, et al
Monitoring and management of autoimmunity in multiple sclerosis patients treated with alemtuzumab: practical recommendations.
J Neurol. 2018 Mar 10. pii: 10.1007/s00415-018-8822.
PubMed Abstract available

HOTTENROTT T, Schorb E, Fritsch K, Dersch R, et al
The MRZ reaction and a quantitative intrathecal IgG synthesis may be helpful to differentiate between primary central nervous system lymphoma and multiple sclerosis.
J Neurol. 2018 Mar 6. pii: 10.1007/s00415-018-8779.
PubMed Abstract available

LOREFICE L, Fenu G, Pitzalis R, Scalas G, et al
Autoimmune comorbidities in multiple sclerosis: what is the influence on brain volumes? A case-control MRI study.
J Neurol. 2018 Mar 5. pii: 10.1007/s00415-018-8811.
PubMed Abstract available

KANEKO A, Kaneko J, Tominaga N, Kanazawa N, et al
Pitfalls in clinical diagnosis of anti-NMDA receptor encephalitis.
J Neurol. 2018;265:586-596.
PubMed Abstract available

February 2018

BROICHER SD, Filli L, Geisseler O, Germann N, et al
Positive effects of fampridine on cognition, fatigue and depression in patients with multiple sclerosis over 2 years.
J Neurol. 2018 Feb 20. pii: 10.1007/s00415-018-8796.
PubMed Abstract available

VAN DER VUURST DE VRIES RM, Mescheriakova JY, Runia TF, Siepman TAM, et al
Smoking at time of CIS increases the risk of clinically definite multiple sclerosis.
J Neurol. 2018 Feb 20. pii: 10.1007/s00415-018-8780.
PubMed Abstract available

BELL JS, Spencer JI, Yates RL, DeLuca GC, et al
The cortical blood-brain barrier in multiple sclerosis: a gateway to progression?
J Neurol. 2018 Feb 13. pii: 10.1007/s00415-017-8727.
PubMed

ESPOSITO F, Ferre L, Clarelli F, Rocca MA, et al
Effectiveness and baseline factors associated to fingolimod response in a real-world study on multiple sclerosis patients.
J Neurol. 2018 Feb 12. pii: 10.1007/s00415-018-8791.
PubMed Abstract available

ARNETH B
Up-to-date knowledge about the association between multiple sclerosis and the reactivation of human endogenous retrovirus infections.
J Neurol. 2018 Feb 8. pii: 10.1007/s00415-018-8783.
PubMed Abstract available

SOLARO C, Cella M, Signori A, Martinelli V, et al
Identifying neuropathic pain in patients with multiple sclerosis: a cross-sectional multicenter study using highly specific criteria.
J Neurol. 2018 Feb 5. pii: 10.1007/s00415-018-8758.
PubMed Abstract available

KALRON A, Allali G, Achiron A
Cerebellum and cognition in multiple sclerosis: the fall status matters.
J Neurol. 2018 Feb 2. pii: 10.1007/s00415-018-8774.
PubMed Abstract available

WINDER K, Linker RA, Seifert F, Deutsch M, et al
Insular multiple sclerosis lesions are associated with erectile dysfunction.
J Neurol. 2018 Feb 1. pii: 10.1007/s00415-018-8763.
PubMed Abstract available

LANDFELDT E, Castelo-Branco A, Svedbom A, Lofroth E, et al
The long-term impact of early treatment of multiple sclerosis on the risk of disability pension.
J Neurol. 2018 Feb 1. pii: 10.1007/s00415-018-8764.
PubMed Abstract available

FRAU J, Carai M, Coghe G, Fenu G, et al
Long-term follow-up more than 10 years after HSCT: a monocentric experience.
J Neurol. 2018;265:410-416.
PubMed Abstract available

AKDAL G, Tanriverdizade T, Sengun I, Bademkiran F, et al
Vestibular impairment in chronic inflammatory demyelinating polyneuropathy.
J Neurol. 2018;265:381-387.
PubMed Abstract available

WANG R, Lai XH, Liu X, Li YJ, et al
Brain magnetic resonance-imaging findings of anti-N-methyl-D-aspartate receptor encephalitis: a cohort follow-up study in Chinese patients.
J Neurol. 2018;265:362-369.
PubMed Abstract available

HONGELL K, Silva DG, Ritter S, Meier DP, et al
Efficacy and safety outcomes in vitamin D supplement users in the fingolimod phase 3 trials.
J Neurol. 2018;265:348-355.
PubMed Abstract available

January 2018

VOGRIG A, Joubert B, Ducray F, Thomas L, et al
Glioblastoma as differential diagnosis of autoimmune encephalitis.
J Neurol. 2018 Jan 30. pii: 10.1007/s00415-018-8767.
PubMed Abstract available

GILHUS NE, Romi F, Hong Y, Skeie GO, et al
Myasthenia gravis and infectious disease.
J Neurol. 2018 Jan 25. pii: 10.1007/s00415-018-8751.
PubMed Abstract available

FIENE M, Rufener KS, Kuehne M, Matzke M, et al
Electrophysiological and behavioral effects of frontal transcranial direct current stimulation on cognitive fatigue in multiple sclerosis.
J Neurol. 2018 Jan 22. pii: 10.1007/s00415-018-8754.
PubMed Abstract available

LEAVITT VM, Tosto G, Riley CS
Cognitive phenotypes in multiple sclerosis.
J Neurol. 2018 Jan 22. pii: 10.1007/s00415-018-8747.
PubMed Abstract available

DI GREGORIO M, Gaetani L, Eusebi P, Floridi P, et al
Treatment of multiple sclerosis relapses with high-dose methylprednisolone reduces the evolution of contrast-enhancing lesions into persistent black holes.
J Neurol. 2018 Jan 11. pii: 10.1007/s00415-017-8726.
PubMed Abstract available

MCMACKEN G, Whittaker RG, Evangelista T, Abicht A, et al
Congenital myasthenic syndrome with episodic apnoea: clinical, neurophysiological and genetic features in the long-term follow-up of 19 patients.
J Neurol. 2018;265:194-203.
PubMed Abstract available

ALENDA R, Costa-Frossard L, Alvarez-Lafuente R, Espejo C, et al
Blood lymphocyte subsets identify optimal responders to IFN-beta in MS.
J Neurol. 2018;265:24-31.
PubMed Abstract available

December 2017

FRAU J, Villar LM, Sardu C, Secci MA, et al
Intrathecal oligoclonal bands synthesis in multiple sclerosis: is it always a prognostic factor?
J Neurol. 2017 Dec 22. pii: 10.1007/s00415-017-8716.
PubMed Abstract available

BRENTON JN, Schreiner T, Karoscik K, Richter M, et al
Attitudes, perceptions, and use of marijuana in youth with multiple sclerosis.
J Neurol. 2017 Dec 22. pii: 10.1007/s00415-017-8715.
PubMed Abstract available

SHRIBMAN S, Hasan H, Hadavi S, Giovannoni G, et al
The BRAIN test: a keyboard-tapping test to assess disability and clinical features of multiple sclerosis.
J Neurol. 2017 Dec 4. pii: 10.1007/s00415-017-8690.
PubMed Abstract available

November 2017

THALER C, Faizy TD, Sedlacik J, Bester M, et al
The use of multiparametric quantitative magnetic resonance imaging for evaluating visually assigned lesion groups in patients with multiple sclerosis.
J Neurol. 2017 Nov 20. doi: 10.1007/s00415-017-8683.
PubMed Abstract available

CONRADSSON D, Ytterberg C, von Koch L, Johansson S, et al
Changes in disability in people with multiple sclerosis: a 10-year prospective study.
J Neurol. 2017 Nov 20. doi: 10.1007/s00415-017-8676.
PubMed Abstract available

ELIASDOTTIR O, Hildeman A, Longfils M, Nerman O, et al
A nationwide survey of the influence of month of birth on the risk of developing multiple sclerosis in Sweden and Iceland.
J Neurol. 2017 Nov 20. doi: 10.1007/s00415-017-8665.
PubMed Abstract available

RUPRECHT K, Wildemann B, Jarius S
Low intrathecal antibody production despite high seroprevalence of Epstein-Barr virus in multiple sclerosis: a review of the literature.
J Neurol. 2017 Nov 2. doi: 10.1007/s00415-017-8656.
PubMed Abstract available

October 2017

COMI G, Patti F, Rocca MA, Mattioli FC, et al
Efficacy of fingolimod and interferon beta-1b on cognitive, MRI, and clinical outcomes in relapsing-remitting multiple sclerosis: an 18-month, open-label, rater-blinded, randomised, multicentre study (the GOLDEN study).
J Neurol. 2017 Oct 23. doi: 10.1007/s00415-017-8642.
PubMed Abstract available

PARDO G, Jones DE
Correction to: The sequence of disease-modifying therapies in relapsing multiple sclerosis: safety and immunologic considerations.
J Neurol. 2017 Oct 23. doi: 10.1007/s00415-017-8633.
PubMed Abstract available

ABBOUD H, Rossman I, Mealy MA, Hill E, et al
Neuronal autoantibodies: differentiating clinically relevant and clinically irrelevant results.
J Neurol. 2017 Oct 3. doi: 10.1007/s00415-017-8627.
PubMed Abstract available

September 2017

WANG L, Zhang S, Xi J, Li W, et al
Efficacy and safety of tacrolimus for myasthenia gravis: a systematic review and meta-analysis.
J Neurol. 2017 Sep 18. doi: 10.1007/s00415-017-8616.
PubMed Abstract available

LOREFICE L, Coghe G, Fenu G, Porta M, et al
'Timed up and go' and brain atrophy: a preliminary MRI study to assess functional mobility performance in multiple sclerosis.
J Neurol. 2017 Sep 11. doi: 10.1007/s00415-017-8612.
PubMed Abstract available

PARDO G, Jones DE
The sequence of disease-modifying therapies in relapsing multiple sclerosis: safety and immunologic considerations.
J Neurol. 2017 Sep 6. doi: 10.1007/s00415-017-8594.
PubMed Abstract available

August 2017

LATTANZI S, Danni M, Taffi R, Cerqua R, et al
Persistence to oral disease-modifying therapies in multiple sclerosis patients.
J Neurol. 2017 Aug 22. doi: 10.1007/s00415-017-8595.
PubMed Abstract available

HRASTELJ J, Robertson N
Genetics of disease severity in multiple sclerosis, Alzheimer's disease, and Huntington's disease: rejuvenating genome-wide association studies.
J Neurol. 2017 Aug 7. doi: 10.1007/s00415-017-8584.
PubMed

FINKE C, Bartels F, Lutt A, Pruss H, et al
High prevalence of neuronal surface autoantibodies associated with cognitive deficits in cancer patients.
J Neurol. 2017 Aug 7. doi: 10.1007/s00415-017-8582.
PubMed Abstract available

July 2017

EICHINGER P, Wiestler H, Zhang H, Biberacher V, et al
A novel imaging technique for better detecting new lesions in multiple sclerosis.
J Neurol. 2017 Jul 29. doi: 10.1007/s00415-017-8576.
PubMed Abstract available

SCHOSER B, Eymard B, Datt J, Mantegazza R, et al
Erratum to: Lambert-Eaton myasthenic syndrome (LEMS): a rare autoimmune presynaptic disorder often associated with cancer.
J Neurol. 2017 Jul 10. doi: 10.1007/s00415-017-8556.
PubMed

June 2017

CASEY JP, Hirouchi T, Hisatsune C, Lynch B, et al
A novel gain-of-function mutation in the ITPR1 suppressor domain causes spinocerebellar ataxia with altered Ca2+ signal patterns.
J Neurol. 2017 Jun 15. doi: 10.1007/s00415-017-8545.
PubMed Abstract available

SCHOSER B, Eymard B, Datt J, Mantegazza R, et al
Lambert-Eaton myasthenic syndrome (LEMS): a rare autoimmune presynaptic disorder often associated with cancer.
J Neurol. 2017 Jun 12. doi: 10.1007/s00415-017-8541.
PubMed Abstract available

HAGSTROM IT, Schneider R, Bellenberg B, Salmen A, et al
Relevance of early cervical cord volume loss in the disease evolution of clinically isolated syndrome and early multiple sclerosis: a 2-year follow-up study.
J Neurol. 2017 Jun 9. doi: 10.1007/s00415-017-8537.
PubMed Abstract available

May 2017

BRITZE J, Pihl-Jensen G, Frederiksen JL
Retinal ganglion cell analysis in multiple sclerosis and optic neuritis: a systematic review and meta-analysis.
J Neurol. 2017 May 31. doi: 10.1007/s00415-017-8531.
PubMed Abstract available

DIBLEY L, Coggrave M, McClurg D, Woodward S, et al
"It's just horrible": a qualitative study of patients' and carers' experiences of bowel dysfunction in multiple sclerosis.
J Neurol. 2017 May 26. doi: 10.1007/s00415-017-8527.
PubMed Abstract available

RATH J, Mauritz M, Zulehner G, Hilger E, et al
Iodinated contrast agents in patients with myasthenia gravis: a retrospective cohort study.
J Neurol. 2017 May 26. doi: 10.1007/s00415-017-8518.
PubMed Abstract available

RIVIERE E, Cohen Aubart F, Maisonobe T, Maurier F, et al
Clinicopathological features of multiple mononeuropathy associated with systemic lupus erythematosus: a multicenter study.
J Neurol. 2017 May 23. doi: 10.1007/s00415-017-8519.
PubMed Abstract available

FOULON S, Maura G, Dalichampt M, Alla F, et al
Prevalence and mortality of patients with multiple sclerosis in France in 2012: a study based on French health insurance data.
J Neurol. 2017 May 17. doi: 10.1007/s00415-017-8513.
PubMed Abstract available

CORDTS I, Bodart N, Hartmann K, Karagiorgou K, et al
Screening for lipoprotein receptor-related protein 4-, agrin-, and titin-antibodies and exploring the autoimmune spectrum in myasthenia gravis.
J Neurol. 2017 May 17. doi: 10.1007/s00415-017-8514.
PubMed Abstract available

LATTANZI S, Cagnetti C, Danni M, Provinciali L, et al
Oral and intravenous steroids for multiple sclerosis relapse: a systematic review and meta-analysis.
J Neurol. 2017 May 10. doi: 10.1007/s00415-017-8505.
PubMed Abstract available

April 2017

HARDING K, Tilling K, MacIver C, Willis M, et al
Seasonal variation in multiple sclerosis relapse.
J Neurol. 2017 Apr 19. doi: 10.1007/s00415-017-8485.
PubMed Abstract available

SARTORI A, Abdoli M, Freedman MS
Can we predict benign multiple sclerosis? Results of a 20-year long-term follow-up study.
J Neurol. 2017 Apr 17. doi: 10.1007/s00415-017-8487.
PubMed Abstract available

HAINLINE C, Rizzo JR, Hudson TE, Dai W, et al
Capturing saccades in multiple sclerosis with a digitized test of rapid number naming.
J Neurol. 2017 Apr 7. doi: 10.1007/s00415-017-8484.
PubMed Abstract available

CHOI HA, Lee MJ, Chung CS
Characteristics of hypertrophic pachymeningitis in patients with granulomatosis with polyangiitis.
J Neurol. 2017;264:724-732.
PubMed Abstract available

BARTOLINI L, Muscal E
Differences in treatment of anti-NMDA receptor encephalitis: results of a worldwide survey.
J Neurol. 2017;264:647-653.
PubMed Abstract available

March 2017

HONG Y, Skeie GO, Zisimopoulou P, Karagiorgou K, et al
Juvenile-onset myasthenia gravis: autoantibody status, clinical characteristics and genetic polymorphisms.
J Neurol. 2017 Mar 31. doi: 10.1007/s00415-017-8478.
PubMed Abstract available

PREZIOSA P, Martinelli V, Ferre L, Guaschino C, et al
Moyamoya disease mimicking the first attack of multiple sclerosis.
J Neurol. 2017 Mar 17. doi: 10.1007/s00415-017-8458.
PubMed

MCLAUCHLAN D, Robertson NP
B cell treatments for multiple sclerosis.
J Neurol. 2017 Mar 4. doi: 10.1007/s00415-017-8442.
PubMed

KHAN F, Amatya B, Galea MP, Gonzenbach R, et al
Neurorehabilitation: applied neuroplasticity.
J Neurol. 2017;264:603-615.
PubMed Abstract available

February 2017

NIJ BIJVANK JA, Balk LJ, Tan HS, Uitdehaag BM, et al
A rare cause for visual symptoms in multiple sclerosis: posterior internuclear ophthalmoplegia of Lutz, a historical misnomer.
J Neurol. 2017 Feb 13. doi: 10.1007/s00415-017-8412.
PubMed

MALONEY E, Molloy A, Al Hussona M, O'Donnell L, et al
Natalizumab-associated progressive multifocal leukoencephalopathy: successful treatment without plasma exchange and its associated risks.
J Neurol. 2017;264:401-403.
PubMed

January 2017

BIANCHI A, Bartolini E, Melani F, Guerrini R, et al
Isolated recurrent myelitis in a 7-year-old child with serum aquaporin-4 IgG antibodies.
J Neurol. 2017;264:179-181.
PubMed

December 2016

GIORLI E, Franciotta D, Beronio A, Amodeo C, et al
Late AQP4-IgG seroconversion and shrinking of brainstem MRI lesions in a patient with overlapping CIS/NMOSD.
J Neurol. 2016;263:2549-2551.
PubMed

HUSS AM, Halbgebauer S, Ockl P, Trebst C, et al
Importance of cerebrospinal fluid analysis in the era of McDonald 2010 criteria: a German-Austrian retrospective multicenter study in patients with a clinically isolated syndrome.
J Neurol. 2016;263:2499-2504.
PubMed Abstract available

HUANG Q, Wu Y, Qin R, Wei X, et al
Clinical characteristics and outcomes between children and adults with anti-N-Methyl-D-Aspartate receptor encephalitis.
J Neurol. 2016;263:2446-2455.
PubMed Abstract available

November 2016

BLOCK VJ, Lizee A, Crabtree-Hartman E, Bevan CJ, et al
Continuous daily assessment of multiple sclerosis disability using remote step count monitoring.
J Neurol. 2016.
PubMed Abstract available

October 2016

PIETRZAK K, Grzybowski A, Kaczmarczyk J
Georges Guillain (1876-1961).
J Neurol. 2016;263:2148-9.
PubMed

ABSINTA M, Reich DS, Filippi M
Spring cleaning: time to rethink imaging research lines in MS?
J Neurol. 2016;263:1893-902.
PubMed Abstract available

September 2016

MAILLART E, Papeix C, Mellerio C, Bertrand A, et al
Extensive and severe CNS demyelination associated with golimumab therapy.
J Neurol. 2016;263:1869-71.
PubMed

LOZERON P, Ribrag V, Adams D, Brisset M, et al
Is distal motor and/or sensory demyelination a distinctive feature of anti-MAG neuropathy?
J Neurol. 2016;263:1761-70.
PubMed Abstract available

ANNOVAZZI P, Capobianco M, Moiola L, Patti F, et al
Rituximab in the treatment of Neuromyelitis optica: a multicentre Italian observational study.
J Neurol. 2016;263:1727-35.
PubMed Abstract available

August 2016

ZURAWSKI J, Flinn A, Sklover L, Sloane JA, et al
Relapse frequency in transitioning from natalizumab to dimethyl fumarate: assessment of risk factors.
J Neurol. 2016;263:1511-7.
PubMed Abstract available

July 2016

ZHOU H, Zhao S, Yin D, Chen X, et al
Optic neuritis: a 5-year follow-up study of Chinese patients based on aquaporin-4 antibody status and ages.
J Neurol. 2016;263:1382-9.
PubMed Abstract available

JEONG IH, Kim HJ, Kim NH, Jeong KS, et al
Subclinical primary retinal pathology in neuromyelitis optica spectrum disorder.
J Neurol. 2016;263:1343-8.
PubMed Abstract available

BALK LJ, Cruz-Herranz A, Albrecht P, Arnow S, et al
Timing of retinal neuronal and axonal loss in MS: a longitudinal OCT study.
J Neurol. 2016;263:1323-31.
PubMed Abstract available

HAVRDOVA E, Belova A, Goloborodko A, Tisserant A, et al
Activity of secukinumab, an anti-IL-17A antibody, on brain lesions in RRMS: results from a randomized, proof-of-concept study.
J Neurol. 2016;263:1287-95.
PubMed Abstract available

June 2016

BRIER MR, Day GS, Snyder AZ, Tanenbaum AB, et al
N-methyl-D-aspartate receptor encephalitis mediates loss of intrinsic activity measured by functional MRI.
J Neurol. 2016;263:1083-91.
PubMed Abstract available

GRIMM A, Vittore D, Schubert V, Rasenack M, et al
Ultrasound aspects in therapy-naive CIDP compared to long-term treated CIDP.
J Neurol. 2016;263:1074-82.
PubMed Abstract available

May 2016

VINJAM MR, Shanmugarajah P, Ford HL
Ophthalmoplegia heralding the onset of anti-amphiphysin related paraneoplastic stiff person syndrome.
J Neurol. 2016;263:1017-8.
PubMed

Thank you for your interest in scientific medicine.

AMEDEO Autoimmune Disorders is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: